Spondylosis

M13_SPONDYLOSIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M47 Hospital discharge: ICD-9 — 721[0-4] Cause of death: ICD-10 — M47 Cause of death: ICD-9 — 721[0-4] 2 out of 7 registries used, show all original rules.	28159
4. Check minimum number of events None	28159
5. Include endpoints None	28159
6. Filter based on genotype QC (FinnGen only)	28159

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M45-M49
Name in latin: Spondylosis

NAME	M13_SPONDYLOSIS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M47
HD_ICD_9	721[0-4]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M47
COD_ICD_9	721[0-4]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spondylosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	176743	94465	81168
Only index persons	157735	86592	71143
Unadjusted period prevalence (%)
Whole population	2.49	2.71	2.27
Only index persons	2.97	3.18	2.72
Median age at first event (years)
Whole population	59.47	60.41	58.26
Only index persons	58.23	59.23	57.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	28159	15806	12353
Unadjusted period prevalence (%)	5.41	5.39	5.45
Median age at first event (years)	58.36	57.79	59.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25147: Matched controls
218755

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

7213A

ICD-9 Finland

Spondylosis and allied disorders, Lumbosacral spondylosis without myelopathy

+∞

323.0

486

L13

ICPC

Hip symptom/complaint

2.6

323.0

4160

15667

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

40.9

323.0

2311

539

A01

ICPC

Pain general/multiple sites

3.7

323.0

2164

5466

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

7844.1

323.0

3196

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

80.4

323.0

622

N06AX21

ATC

duloxetine; oral

6.5

323.0

4533

7138

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

298.5

323.0

3732

128

N03AX12

ATC

gabapentin; oral

11.0

323.0

8138

9076

M03BX02

ATC

tizanidine; oral

3.4

323.0

17760

90033

ACC51

NOMESCO Finland

Release of median nerve

3.5

323.0

2281

6121

M41.9

ICD-10 Finland

Scoliosis, unspecified

28.1

323.0

489

154

M01AH05

ATC

etoricoxib; oral

3.1

323.0

16936

87668

J01FA06

ATC

roxithromycin; oral

1.8

323.0

9769

57818

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

22.1

323.0

897

366

M03BC51

ATC

orphenadrine, combinations; systemic

2.6

323.0

7996

33225

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

6124.3

323.0

694

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

92.1

323.0

478

ZXA00

NOMESCO Finland

Right side

1.9

323.0

6863

36134

M79.7

ICD-10 Finland

Fibromyalgia

7.3

323.0

1074

1332

N02AJ06

ATC

codeine and paracetamol; systemic

3.2

323.0

11207

44325

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

17.6

323.0

5191

3178

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

323.0

2413

6455

SPAT1153

SPAT

Removal of sutures

2.1

323.0

8534

42531

M54

ICD-10 Finland

Dorsalgia

3.5

323.0

3072

8404

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

323.0

9460

53526

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.4

323.0

2003

5504

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

938.7

323.0

1618

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

31.8

323.0

3943

1272

H02AB06

ATC

prednisolone; systemic

2.2

323.0

12178

66323

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

323.0

8976

41454

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.2

323.0

7733

26352

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

2839.7

323.0

654

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

323.0

356

R20.2

ICD-10 Finland

Paraesthesia of skin

3.5

323.0

1737

4565

UJF32

NOMESCO Finland

Coloscopy

2.2

323.0

6871

31957

M25.5

ICD-10 Finland

Pain in joint

2.8

323.0

8070

31844

M01AX05

ATC

glucosamine; oral

2.3

323.0

5608

23887

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.8

323.0

3249

10895

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

95.2

323.0

3563

379

R42

ICD-10 Finland

Dizziness and giddiness

2.3

323.0

5525

24102

M50.3

ICD-10 Finland

Other cervical disc degeneration

54.6

323.0

1379

232

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

323.0

4105

15823

M47.9

ICD-10 Finland

Spondylosis, unspecified

209.1

323.0

4761

244

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

323.0

12033

76846

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

323.0

12986

83081

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

52.3

323.0

443

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

323.0

9775

53993

A02BC02

ATC

pantoprazole; systemic

2.7

323.0

17650

102792

XA402

NOMESCO Finland

ENMG

8.7

323.0

1033

1075

M01AB05

ATC

diclofenac; systemic, rectal

2.6

323.0

17861

106363

L28

ICPC

Limited function/disability (L)

2.7

323.0

4268

15335

L86

ICPC

Back syndrome with radiating pain

10.4

323.0

2458

2246

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

61.8

323.0

4312

729

M45

ICD-10 Finland

Ankylosing spondylitis

49.2

323.0

461

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

323.0

7779

34160

M48.0

ICD-10 Finland

Spinal stenosis

145.4

323.0

8513

768

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

323.0

7107

37908

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

43.7

323.0

479

M01AB55

ATC

diclofenac, combinations; oral

3.5

323.0

2075

5484

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

323.0

4520

17420

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

309.9

323.0

2457

A02BC05

ATC

esomeprazole; systemic

2.4

323.0

11327

55555

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

50.6

323.0

6207

1404

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

8.1

323.0

5641

7501

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

3306.4

323.0

1118

N05CF01

ATC

zopiclone; oral

1.9

323.0

8193

43436

J01DA01

ATC

[U] cefalexin; systemic

1.7

323.0

15022

100857

M53.2

ICD-10 Finland

Spinal instabilities

135.3

323.0

383

N06AA09

ATC

amitriptyline; systemic

5.4

323.0

3936

7316

A02BC03

ATC

lansoprazole; oral

2.4

323.0

8255

36565

A02BA02

ATC

ranitidine; systemic

2.2

323.0

5186

23001

M43.0

ICD-10 Finland

Spondylolysis

144.8

323.0

775

R51.80

ICD-10 Finland

Headache

3.2

323.0

3776

11504

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

323.0

4533

18575

J01FA10

ATC

azithromycin; systemic

1.7

323.0

13049

85538

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.6

323.0

3376

8929

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

213.8

323.0

1846

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

323.0

4279

18801

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.7

323.0

1282

1515

R52.2

ICD-10 Finland

Other chronic pain

7.8

323.0

1268

1479

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

323.0

7467

32115

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.8

323.0

4583

12253

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

323.0

6044

24447

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

1022.1

323.0

348

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

75.3

323.0

990

119

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

935.6

323.0

630

L01

ICPC

Neck symptom/complaint

4.1

323.0

4614

11321

M54.6

ICD-10 Finland

Pain in thoracic spine

6.4

323.0

2078

3052

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

9.3

323.0

918

890

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

18.3

323.0

720

352

M54.4

ICD-10 Finland

Lumbago with sciatica

12.6

323.0

7516

7148

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.4

323.0

14185

60273

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

538.5

323.0

367

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

84.3

323.0

7805

1162

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

323.0

509

M01AH02

ATC

rofecoxib; oral

3.2

323.0

4185

12811

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

1549.8

323.0

1617

L08

ICPC

Shoulder symptom/complaint

2.4

323.0

5098

21060

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

323.0

497

M43.1

ICD-10 Finland

Spondylolisthesis

65.5

323.0

2136

309

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

323.0

11228

68727

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

76.5

323.0

601

M54.2

ICD-10 Finland

Cervicalgia

11.0

323.0

3260

2933

C07AB07

ATC

bisoprolol; oral

1.7

323.0

11481

71981

M01AE02

ATC

naproxen; oral, rectal

2.1

323.0

14135

82838

N02AX02

ATC

tramadol; systemic, rectal

5.1

323.0

15141

50104

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

919.0

323.0

11612

201

N03AX16

ATC

pregabalin; oral

9.5

323.0

11587

18116

R01AD09

ATC

mometasone; nasal

1.7

323.0

10194

62047

A02BC01

ATC

omeprazole; systemic

2.3

323.0

7555

34034

M02AA07

ATC

piroxicam; topical

2.0

323.0

9573

51399

M54.9

ICD-10 Finland

Dorsalgia, unspecified

8.9

323.0

3820

4319

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

19.8

323.0

997

455

N03AE01

ATC

clonazepam; systemic

3.6

323.0

1666

4249

R03AC02

ATC

salbutamol; inhalant

2.1

323.0

13029

74662

N02BE01

ATC

paracetamol; systemic, rectal

4.3

323.0

22833

152196

M01AC06

ATC

meloxicam; systemic, rectal

2.6

323.0

10645

48791

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

323.0

10204

51729

J01DB01

ATC

cefalexin; oral

2.0

323.0

19894

142526

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

323.0

14250

95606

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

23.3

323.0

1064

414

G44.2

ICD-10 Finland

Tension-type headache

3.4

323.0

3690

10669

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

323.0

4915

22029

N06AX11

ATC

mirtazapine; oral

2.2

323.0

8326

39636

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

323.0

5597

27599

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.1

323.0

1218

2180

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.7

323.0

3175

8295

N02AA05

ATC

oxycodone; systemic

2.8

323.0

4090

14288

S18

ICPC

Laceration/cut

2.1

323.0

11121

59026

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

323.0

3639

14139

WX110

NOMESCO Finland

Local anesthesy

1.9

323.0

16498

109393

M47.82

ICD-10 Finland

Other spondylosis, cervical region

124.7

323.0

5683

511

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

323.0

4161

17537

M54.1

ICD-10 Finland

Radiculopathy

28.3

323.0

2007

668

L02

ICPC

Back symptom/complaint

3.7

323.0

2443

6190

L03

ICPC

Low back symptom/complaint

4.7

323.0

8219

20297

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

19.2

323.0

1176

558

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

84.4

323.0

3895

475

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.0

323.0

8765

33431

R4110

NOMESCO Finland

Physiotherapy

2.0

323.0

7031

34820

Z50.1

ICD-10 Finland

Other physical therapy

3.6

323.0

1700

4275

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

323.0

6389

29167

M01AH01

ATC

celecoxib; oral (coxibs)

3.3

323.0

5941

18815

R06.0

ICD-10 Finland

Dyspnoea

2.3

323.0

6457

28388

M70.6

ICD-10 Finland

Trochanteric bursitis

3.8

323.0

3837

9796

R52.9

ICD-10 Finland

Pain, unspecified

3.0

323.0

2158

6710

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

59.1

323.0

579

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

259.6

323.0

466

N02AC04

ATC

dextropropoxyphene; oral

5.0

323.0

1187

2142

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

323.0

16415

110752

7210A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis without myelopathy

+∞

323.0

514

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

19.8

323.0

2371

1143

N05BA01

ATC

diazepam; systemic, rectal

2.4

323.0

3478

13769

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

323.0

9896

58213

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

323.0

22098

163642

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

407.6

323.0

462

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

323.0

7915

35703

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

128.6

323.0

436

J01AA02

ATC

doxycycline; systemic

2.1

323.0

19717

138245

L17

ICPC

Foot/toe symptom/complaint

2.1

323.0

6078

29245

R5599

NOMESCO Finland

Other rehabilitation service

6.6

323.0

902

1221

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

7.3

323.0

2952

3933

M01AX17

ATC

nimesulide; oral

2.5

323.0

7133

30020

M03BC01

ATC

orphenadrine (citrate); systemic

3.7

323.0

7464

22568

M54.5

ICD-10 Finland

Low back pain

6.5

323.0

11549

25320

N06AX16

ATC

venlafaxine; oral

3.0

323.0

3773

12307

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

873.2

323.0

1333

M53.0

ICD-10 Finland

Cervicocranial syndrome

4.2

323.0

2423

5435

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

323.0

4760

20102

G54.0

ICD-10 Finland

Brachial plexus disorders

11.0

323.0

984

805

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

323.0

5378

24072

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

323.0

1105

M53.1

ICD-10 Finland

Cervicobrachial syndrome

7.2

323.0

4386

6196

NF1AA

NOMESCO Finland

Hip X-ray examination

2.9

323.0

2284

7313

M47.8

ICD-10 Finland

Other spondylosis

250.9

323.0

479

M54.3

ICD-10 Finland

Sciatica

13.9

323.0

2280

1560

9211

FHL

Exploration or removal of diskusprolapse

453.9

323.0

663

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1593.3

323.0

1654

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

323.0

10605

62902

M79.1

ICD-10 Finland

Myalgia

2.9

323.0

3328

10883

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

323.0

1911

5179

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.4

323.0

2081

5603

M79.6

ICD-10 Finland

Pain in limb

3.1

323.0

10631

42143

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

871.5

323.0

395

M54.8

ICD-10 Finland

Other dorsalgia

5.7

321.2

1008

1602

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.2

319.2

1908

5532

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.4

318.6

1033

1707

R53

ICD-10 Finland

Malaise and fatigue

2.0

313.8

4627

21788

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

313.6

4370

20107

AA1AD

NOMESCO Finland

CT of head and brain

1.9

313.4

5671

28893

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

311.7

6399

34082

ZXA05

NOMESCO Finland

Left side

1.9

310.2

6329

33625

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

705.8

309.0

321

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

308.6

312

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.5

307.6

1609

4217

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.6

5317

26606

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

6.2

306.8

896

1299

J01MA02

ATC

ciprofloxacin; systemic

1.7

305.7

9230

55468

SPAT1301

SPAT

No procedures

1.8

304.4

7234

40381

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.7

303.6

1451

3532

ZZH40

NOMESCO Finland

Substitute of bone

16.5

302.3

516

278

P01AB01

ATC

metronidazole; oral, rectal

1.7

300.9

9153

55055

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

299.6

8632

51077

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

108.3

299.6

344

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

296.7

4322

20198

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

295.1

14116

96031

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.1

294.2

1823

5409

SPAT1263

SPAT

Sampling

1.7

294.1

9506

58075

N06AB04

ATC

citalopram; systemic

1.9

293.9

5100

25495

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

388.2

293.1

310

J02AC01

ATC

fluconazole; systemic

1.7

291.7

8872

53226

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

291.4

2598

9639

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

43.1

291.1

381

L15

ICPC

Knee symptom/complaint

1.9

288.2

4814

23701

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

4.7

287.6

1072

2065

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

870.3

287.2

297

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

129.7

287.0

324

B01AB05

ATC

enoxaparin; parenteral

1.7

286.3

7290

41411

J01CA04

ATC

amoxicillin; systemic

1.7

285.9

18572

136713

J01FF01

ATC

clindamycin; systemic

1.8

285.8

6444

35221

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

285.8

289

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

285.6

2865

11296

WZA90

NOMESCO Finland

Other doctors statement

1.9

284.3

5151

26115

R06AE07

ATC

cetirizine; oral

1.7

282.1

9627

59506

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.3

282.0

3033

12369

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

281.0

7614

44025

N05BA04

ATC

oxazepam; oral

1.8

279.8

5685

29977

N04BC05

ATC

pramipexole; oral

2.9

278.5

1921

6116

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

277.5

12865

86161

M01AX01

ATC

nabumetone; oral

3.8

275.7

1292

3087

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

27.1

272.2

396

129

M01AB08

ATC

etodolac; oral

2.8

271.7

2013

6697

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

270.1

2644

10277

R03DC03

ATC

montelukast; oral

2.1

269.9

3662

16551

K02.1

ICD-10 Finland

Caries of dentine

1.6

268.8

12419

82808

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

273.3

262.7

282

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

209.6

262.4

286

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.1

261.0

1125

2494

R07.3

ICD-10 Finland

Other chest pain

2.5

260.6

2267

8269

SPAT1310

SPAT

Counselling related to known health issue

1.7

260.3

7096

40894

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

259.6

6725

38162

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

258.8

1836

5942

L84

ICPC

Back syndrome without radiat pain

4.1

258.6

1114

2468

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

28.2

257.7

371

116

J01FA09

ATC

clarithromycin; systemic

1.7

257.3

7206

41821

A06AD11

ATC

lactulose; oral

2.1

256.9

3398

15166

K30

ICD-10 Finland

Functional dyspepsia

2.4

256.7

2468

9491

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.8

254.4

1781

5712

N06AA10

ATC

nortriptyline; systemic

6.5

254.3

712

974

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

253.5

2764

11308

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

253.1

256

WX402

NOMESCO Finland

General anaesthesia

2.0

249.0

4033

19495

L83

ICPC

Neck syndrome

14.9

249.0

441

261

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

247.1

4429

22218

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.4

246.1

964

1949

R52.1

ICD-10 Finland

Chronic intractable pain

19.5

245.6

394

178

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

22.7

245.0

375

146

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

242.3

9240

58113

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

242.2

11251

74350

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.7

242.2

1884

6439

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.0

241.6

717

1059

M01AH03

ATC

valdecoxib; oral

2.8

241.1

1704

5491

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.3

241.1

982

2062

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

239.3

10122

65288

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

238.9

2602

10620

M02AA10

ATC

ketoprofen; topical

2.0

237.9

3787

18157

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

236.2

239

Z71.8

ICD-10 Finland

Other specified counselling

1.8

236.1

5078

27047

SPAT1312

SPAT

General health counselling

1.7

235.2

6865

40099

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.4

234.1

2145

8025

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

232.5

3905

19086

SPAT1216

SPAT

Assessment of functional ability

2.0

232.0

3479

16284

R02

ICPC

Shortness of breath/dyspnoea

2.2

231.9

2698

11346

7214A

ICD-9 Finland

Spondylosis and allied disorders, Thoracic or lumbar spondylosis with myelopathy

+∞

228.3

231

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.8

226.5

1632

5317

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

226.3

7146

42560

M77.1

ICD-10 Finland

Lateral epicondylitis

2.7

225.3

1724

5824

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.8

224.7

1035

2429

N05CF02

ATC

zolpidem; oral

1.9

223.4

4054

20340

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

222.7

5541

30801

R03BA01

ATC

beclometasone; inhalant

2.0

221.9

3283

15260

Z01.2

ICD-10 Finland

Dental examination

1.6

221.6

8754

55183

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

221.1

2435

9969

L12

ICPC

Hand/finger symptom/complaint

2.0

220.5

3073

13945

SPAT1260

SPAT

Consultation of another employee

1.9

218.3

3990

20052

XX2CT

NOMESCO Finland

Other injection with CT guidance

259.5

218.2

235

M01AC01

ATC

piroxicam; systemic, rectal

2.0

218.1

3292

15417

WX308

NOMESCO Finland

Sacral anesthesy

142.8

218.0

244

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

217.4

220

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.7

216.4

670

1043

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

216.0

2242

8917

L29

ICPC

Musculoskeletal sympt/complt other

2.6

215.8

1767

6205

M48.9

ICD-10 Finland

Spondylopathy, unspecified

126.0

215.7

244

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

215.4

2687

11631

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.4

215.0

851

1736

TAB20

NOMESCO Finland

Epidural puncture

22.1

214.8

331

132

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.0

214.3

1339

3971

KMAK

NOMESCO Finland

1.5

214.0

11245

75668

SPAT1229

SPAT

Assessment of need for aid

2.5

213.6

1903

6999

A03FA02

ATC

cisapride; oral, rectal

2.5

213.5

1901

6988

P01BA02

ATC

hydroxychloroquine; oral

2.4

213.3

2000

7555

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

212.9

1449

4549

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

212.5

2532

10734

X58

ICD-10 Finland

Exposure to other specified factors

2.0

211.9

2975

13523

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

211.6

1635

5549

UKC02

NOMESCO Finland

Cystoscopy

1.9

211.3

3704

18320

R01AD12

ATC

fluticasone furoate; nasal

1.7

210.8

6158

35759

ZXA10

NOMESCO Finland

Bilateral

1.8

210.2

4325

22590

N02AJ13

ATC

tramadol and paracetamol; systemic

6.4

208.8

592

823

R05

ICD-10 Finland

Cough

1.8

208.0

4240

22071

R05FB02

ATC

cough suppressants and expectorants

1.6

206.8

8768

55969

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

52.1

206.6

261

N05AH04

ATC

quetiapine; oral

1.9

205.3

3362

16206

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

205.2

1888

7057

A07EC01

ATC

sulfasalazine; oral, rectal

2.5

204.9

1833

6751

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

204.2

9595

62692

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

204.1

2258

9246

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

11.9

203.8

398

295

N06AB10

ATC

escitalopram; oral

1.8

203.2

4025

20737

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.8

203.0

1455

4715

R03BA02

ATC

budesonide; inhalant

1.8

202.7

3846

19526

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

11.4

202.6

404

313

G04BD12

ATC

mirabegron; oral

2.2

201.9

2386

10065

R13

ICD-10 Finland

Dysphagia

2.6

199.9

1579

5424

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

199.8

9376

61144

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.7

198.9

620

973

R01AD08

ATC

fluticasone; nasal

1.6

197.8

6132

36070

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.3

197.6

2026

7994

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.0

197.6

2898

13376

C10AA05

ATC

atorvastatin; oral

1.5

197.3

8900

57464

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

196.2

1924

7425

R60.0

ICD-10 Finland

Localized oedema

2.1

196.2

2506

10928

J01EA01

ATC

trimethoprim; systemic

1.7

196.0

5392

30678

WX290

NOMESCO Finland

Other blockade of nerve

1.5

196.0

8983

58187

C10AA07

ATC

rosuvastatin; oral

1.7

195.2

5624

32408

C08CA01

ATC

amlodipine; oral

1.5

194.9

8261

52524

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

194.7

1642

5849

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

193.0

9168

59808

M50.8

ICD-10 Finland

Other cervical disc disorders

89.8

192.2

225

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

191.6

7964

50344

R05

ICPC

Cough

1.7

191.2

4603

25167

C07AA05

ATC

propranolol; systemic

1.8

191.0

4117

21751

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.2

190.3

1110

3131

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

35.0

189.8

259

N06AB03

ATC

fluoxetine; oral

2.0

189.4

2812

13028

R03AC03

ATC

terbutaline; inhalant

1.9

188.8

3078

14775

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.8

188.2

1310

4164

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.6

187.3

921

2280

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

187.1

4698

25984

H02AB04

ATC

methylprednisolone; systemic

1.9

187.0

3276

16134

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.8

186.6

862

2024

C03CA01

ATC

furosemide; systemic

1.6

185.2

6192

37032

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

184.4

1623

5915

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

182.6

3081

14961

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

181.9

1744

6645

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

22.6

181.9

278

108

C10AA01

ATC

simvastatin; oral

1.5

181.4

10006

67175

R06AX27

ATC

desloratadine; oral

1.6

179.7

5394

31314

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

178.8

3220

15990

D07AC01

ATC

betamethasone; topical

1.5

178.7

7538

47627

C01DA14

ATC

isosorbide mononitrate; oral

1.8

178.3

3306

16583

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

177.2

2457

11058

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

176.0

5586

32884

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.2

175.9

723

1527

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

175.7

3586

18565

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

403.6

175.3

185

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

174.5

2082

8792

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

172.4

4131

22467

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

172.1

1812

7220

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

172.1

3193

16003

R03BA05

ATC

fluticasone; inhalant

1.8

170.9

3779

20047

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

170.5

5830

34932

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

169.7

1728

6772

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

169.4

1237

4044

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

168.4

6151

37438

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

168.3

4810

27482

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

167.8

1363

4744

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

167.2

3004

14877

N03AX09

ATC

lamotrigine; oral

3.1

167.2

995

2845

N30.0

ICD-10 Finland

Acute cystitis

1.9

167.0

2782

13411

XKD00

NOMESCO Finland

Uroflowmetry

1.8

166.7

3587

18851

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

752.1

165.8

172

G04CA02

ATC

tamsulosin; oral

1.6

164.8

4878

28114

M15

ICD-10 Finland

Polyarthrosis

2.8

164.5

1170

3763

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.7

164.3

378

383

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

164.0

1467

5381

A02BA04

ATC

nizatidine; systemic

2.2

163.9

1838

7538

M47

ICD-10 Finland

Spondylosis

11.0

163.0

330

264

M03BX01

ATC

baclofen; systemic

5.6

162.8

514

819

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

51.3

162.0

205

U02

ICPC

Urinary frequency/urgency

1.9

161.5

2666

12799

-1

NOMESCO Finland

1.5

161.4

6684

41825

N05CD07

ATC

temazepam; oral

1.9

161.0

2836

13936

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

161.0

163

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.8

160.7

578

1067

R96

ICPC

Asthma

2.2

160.7

1857

7716

A01AB09

ATC

miconazole; local oral

2.1

160.1

1976

8452

E0000UV

ATC

1.5

159.9

8238

54066

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

159.6

4186

23306

EBA00

NOMESCO Finland

Extraction of tooth

1.5

159.5

6765

42538

M75.8

ICD-10 Finland

Other shoulder lesions

3.5

158.9

812

2071

N01

ICPC

Headache

2.3

158.6

1658

6575

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

40.7

158.3

209

R1250

NOMESCO Finland

Evaluation of functional capability

4.3

158.1

630

1291

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

157.5

1569

6078

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

157.2

1512

5754

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.5

157.1

1337

4771

R35

ICD-10 Finland

Polyuria

2.4

157.1

1441

5354

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

19.1

157.1

253

116

M76.0

ICD-10 Finland

Gluteal tendinitis

6.9

156.9

420

539

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

156.0

1627

6445

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

155.7

1362

4935

J45

ICD-10 Finland

Asthma

2.1

155.6

2057

9056

Z01.9

ICD-10 Finland

Special examination, unspecified

2.5

154.7

1352

4893

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

154.3

3498

18645

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

154.2

1589

6258

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

153.5

2676

13085

R03BB04

ATC

tiotropium bromide; inhalant

2.0

152.5

2211

10098

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

152.2

1550

6066

J01CA08

ATC

pivmecillinam; oral

1.5

151.9

7884

51677

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

151.8

1826

7718

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.9

151.5

995

3038

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

151.3

1003

3081

L14

ICPC

Leg/thigh symptom/complaint

2.3

151.0

1572

6216

A04

ICPC

Weakness/tiredness general

1.9

151.0

2477

11846

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

151.0

7016

44903

P03

ICPC

Feeling depressed

2.3

150.9

1497

5782

WX002

NOMESCO Finland

Sedation and analgesia

1.6

150.7

4387

25090

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

150.2

2337

10962

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

+∞

150.1

152

M35.7

ICD-10 Finland

Hypermobility syndrome

9.6

149.8

325

297

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

149.3

3624

19692

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

149.3

2358

11119

A02BC04

ATC

rabeprazole; oral

2.1

148.3

1819

7750

L16

ICPC

Ankle symptom/complaint

2.0

147.5

1978

8750

M19.8

ICD-10 Finland

Other specified arthrosis

3.1

146.3

859

2430

C07AB02

ATC

metoprolol; systemic

1.6

146.2

4520

26236

R21

ICPC

Throat symptom/complaint

1.7

145.7

3271

17352

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

145.1

1154

3960

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

144.9

5888

36507

K07.60

ICD-10 Finland

Snapping jaw

2.9

144.8

953

2913

R51

ICD-10 Finland

Headache

2.8

144.7

1033

3326

M76.6

ICD-10 Finland

Achilles tendinitis

3.2

144.6

828

2300

SPAT1240

SPAT

Therapeutic discussion

2.1

144.6

1846

7997

SPAT1058

SPAT

PEF monitoring instruction

2.1

144.3

1770

7538

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

143.9

1860

8099

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

16.5

143.7

244

130

H02AB07

ATC

prednisone; oral

1.8

143.6

3074

16065

M13.9

ICD-10 Finland

Arthritis, unspecified

2.2

143.5

1558

6280

9201

FHL

Anterior decompression surgery (also includes dees)

330.5

142.9

152

SPAT1254

SPAT

Administration of medicine

1.8

142.9

2903

14921

A28

ICPC

Limited function/disability NOS

1.8

142.8

3035

15820

XF402

NOMESCO Finland

ECG with work load test

1.9

142.6

2512

12305

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

142.6

3973

22412

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.2

142.5

580

1213

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

142.4

4820

28600

Z00.0

ICD-10 Finland

General medical examination

1.7

141.5

3760

20935

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

140.9

2786

14188

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

58.5

140.6

174

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.6

140.3

1142

3971

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

140.3

2369

11430

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

139.7

4608

27148

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.0

139.3

338

374

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

139.0

2853

14700

R01AD01

ATC

beclometasone; nasal

1.7

138.8

3271

17584

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.1

138.3

1713

7321

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.0

138.3

593

1302

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

137.6

1551

6358

H02BX01

ATC

methylprednisolone, combinations; systemic

2.4

137.4

1230

4504

SPAT1097

SPAT

Recording of ECG

1.7

137.0

3216

17261

NG1DA

NOMESCO Finland

X-ray of knees

4.5

136.9

518

1008

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

136.6

2853

14775

XKC03

NOMESCO Finland

Water cystometry

3.2

136.5

774

2134

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

6.5

135.9

377

509

M41.8

ICD-10 Finland

Other forms of scoliosis

28.0

135.7

195

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.4

135.7

1314

5009

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

135.4

1254

4671

M01AE51

ATC

ibuprofen, combinations; systemic

4.9

135.2

477

863

C10AX09

ATC

ezetimibe; oral

1.8

134.8

2432

11997

D01

ICPC

Abdominal pain/cramps general

2.0

133.9

1929

8765

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

133.6

2276

11008

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

133.6

1603

6756

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

55.8

133.2

166

G04BD08

ATC

solifenacin; oral

2.2

133.1

1483

6043

N17

ICPC

Vertigo/dizziness

1.9

131.4

2189

10497

SPAT1325

SPAT

Vaccination

1.5

131.3

7126

46794

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

131.2

2731

14115

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

131.0

2424

12055

M70.7

ICD-10 Finland

Other bursitis of hip

3.8

131.0

609

1436

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.5

130.8

504

999

M09AX01

ATC

hyaluronic acid; parenteral

2.4

130.8

1173

4297

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

130.0

6618

42878

C08CA13

ATC

lercanidipine; oral

1.7

129.7

2881

15189

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.8

129.6

899

2840

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.8

129.4

887

2783

S06.0

ICD-10 Finland

Concussion

1.9

129.1

1979

9206

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

128.7

1660

7209

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

128.4

4551

27214

SPAT1211

SPAT

Application of soft bandage

2.0

128.2

1893

8676

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

128.1

1998

9353

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

127.8

2308

11379

R4120

NOMESCO Finland

Occupational therapy

2.2

127.7

1413

5739

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

7.5

127.4

320

374

K59.0

ICD-10 Finland

Constipation

2.4

127.2

1158

4274

M01AE52

ATC

naproxen and esomeprazole; oral

3.0

127.1

791

2327

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

126.7

753

2145

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

125.7

995

3402

M50

ICD-10 Finland

Cervical disc disorders

9.6

124.3

269

245

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.1

123.6

516

1105

P06

ICPC

Sleep disturbance

1.9

123.6

1914

8930

A11

ICPC

Chest pain NOS

2.1

123.4

1566

6752

J01MA06

ATC

norfloxacin; oral

1.7

122.6

2911

15633

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

122.6

4807

29378

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

122.5

2319

11608

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.6

122.2

589

1431

J20

ICD-10 Finland

Acute bronchitis

1.9

122.0

1934

9099

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.3

121.5

1227

4768

S29

ICPC

Skin symptom/complaint other

1.6

121.5

3355

18799

A98

ICPC

Health maint/preventive medicine

1.7

121.4

23063

189701

H01

ICPC

Ear pain/earache

1.9

121.3

1870

8707

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

121.3

908

3005

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.1

121.1

715

2028

J01MA12

ATC

levofloxacin; systemic

1.6

120.9

3928

22953

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

120.7

7254

48402

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.6

120.6

973

3361

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

120.5

5608

35559

B01AC04

ATC

clopidogrel; oral

1.6

120.3

3255

18133

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

120.2

5321

33383

WX320

NOMESCO Finland

Spinalanesthesy

1.5

120.1

4747

29049

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

120.0

1819

8413

N05BA12

ATC

alprazolam; oral

1.8

120.0

2161

10631

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

120.0

1580

6916

C05AA08

ATC

fluocortolone; rectal, topical

1.7

120.0

3089

16974

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

119.9

1575

6885

R06.5

ICD-10 Finland

Mouth breathing

1.9

119.6

1862

8698

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

225.9

119.1

129

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

9.7

119.0

256

231

A07AA02

ATC

nystatin; oral

2.2

118.7

1342

5499

7211A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis with myelopathy

+∞

118.5

120

7233A

ICD-9 Finland

Other disorders of cervical region, Cervicobrachial syndrome (diffuse)

+∞

118.5

120

N06AB06

ATC

sertraline; oral

1.9

118.5

2054

9972

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

1065.4

118.4

122

SFA00

NOMESCO Finland

Small filling

1.7

117.9

2626

13830

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

117.7

5079

31663

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.1

117.6

491

1052

M48

ICD-10 Finland

Other spondylopathies

44.3

117.3

152

M01AB01

ATC

indometacin; systemic, rectal

2.0

117.0

1690

7672

R25.2

ICD-10 Finland

Cramp and spasm

3.9

116.8

524

1198

7225A

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]

+∞

116.5

118

R52.0

ICD-10 Finland

Acute pain

3.2

116.5

653

1785

AN1

Coronary angiography

1.7

116.0

2498

13016

NA1BG

SPAT

7.7

115.8

286

326

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

115.8

3981

23556

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

115.6

2912

15892

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

+∞

115.5

117

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

114.8

1056

3916

L04AA13

ATC

leflunomide; oral

3.3

114.8

618

1639

D06

ICPC

Abdominal pain localized other

2.1

114.4

1504

6576

H03AA01

ATC

levothyroxine sodium; systemic

1.5

114.3

4848

30083

N06AA12

ATC

doxepin; systemic

2.3

114.3

1197

4733

M77.4

ICD-10 Finland

Metatarsalgia

2.3

113.9

1097

4165

R15

ICD-10 Finland

Faecal incontinence

3.4

113.7

608

1604

N06AX03

ATC

mianserin; oral

2.4

113.4

1069

4015

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

113.3

912

3147

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

42.8

112.7

147

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

35.2

112.7

153

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

112.5

896

3070

SPAT1262

SPAT

Handing over of treatment supplies

1.6

112.1

3877

22952

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.9

112.1

1757

8220

G04BD04

ATC

oxybutynin; oral, transdermal

2.3

111.9

1164

4586

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

111.3

1033

3847

N03AF01

ATC

carbamazepine; oral, rectal

2.3

110.9

1138

4454

C09CA06

ATC

candesartan; oral

1.5

110.8

4567

28134

L88

ICPC

Rheumatoid/seropositive arthritis

2.7

110.7

811

2649

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

108.9

1951

9568

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.6

108.9

535

1321

H02.3

ICD-10 Finland

Blepharochalasis

2.1

108.8

1364

5841

D11

ICPC

Diarrhoea

1.9

108.2

1896

9228

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

107.8

6003

39295

7227A

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]

+∞

107.6

109

R74

ICPC

Upper respiratory infection acute

1.5

107.2

4803

30094

SPAT1202

SPAT

Intra-articular injection

2.8

106.7

745

2362

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

106.3

14771

112504

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

106.1

1670

7819

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

8.0

105.8

255

280

J05AB01

ATC

aciclovir; systemic

1.5

105.7

4149

25252

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

105.5

1167

4729

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

96.9

105.4

122

NF1DA

NOMESCO Finland

X-ray of hips

3.6

104.9

518

1284

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

104.7

106

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

104.6

648

1901

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

104.6

4163

25408

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

104.3

2993

16882

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

9.0

104.3

234

228

71312

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis

+∞

103.7

105

D07AC13

ATC

mometasone; topical

1.4

103.5

6012

39612

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.2

102.9

415

861

L09

ICPC

Arm symptom/complaint

2.5

102.8

855

3002

1220

FHL

Arthroscopy

2.5

102.8

899

3245

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

102.7

3669

21838

R06AX22

ATC

ebastine; oral

1.6

102.6

3352

19531

R03BA08

ATC

ciclesonide; inhalant

1.9

102.0

1639

7729

ACC53

NOMESCO Finland

Release of ulnar nerve

4.7

101.9

374

706

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

101.8

1323

5748

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

101.8

693

2162

TAC99

NOMESCO Finland

Other blockade for chronic pain

9.4

101.7

222

206

U01

ICPC

Dysuria/painful urination

2.1

101.7

1329

5787

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

101.7

1238

5233

M01AB51

ATC

indometacin, combinations; oral, rectal

3.3

101.5

549

1461

D82

ICPC

Teeth/gum disease

1.4

101.5

6603

44385

C09CA01

ATC

losartan; oral

1.4

101.4

5152

33061

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.3

101.3

983

3741

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

101.1

4521

28267

S22.3

ICD-10 Finland

Fracture of rib

2.1

100.9

1308

5676

R11

ICD-10 Finland

Nausea and vomiting

2.0

100.9

1448

6544

G83.4

ICD-10 Finland

Cauda equina syndrome

30.8

100.8

141

205

Kela drug reimbursment

Chronic hypertension

1.4

100.6

6008

39753

D07AD01

ATC

clobetasol; topical

1.6

100.5

3208

18575

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.9

100.5

1647

7820

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

100.5

1692

8111

NBG10

NOMESCO Finland

Acromioplastia

3.0

100.2

629

1861

P76

ICPC

Depressive disorder

2.3

100.2

1029

4028

7244A

ICD-9 Finland

Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified

+∞

99.7

101

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.6

99.7

808

2797

L90

ICPC

Osteoarthrosis of knee

2.0

99.7

1314

5743

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

99.6

1496

6880

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

99.4

1846

9150

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

4.2

99.4

403

840

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

99.4

1362

6044

L11

ICPC

Wrist symptom/complaint

2.0

99.2

1429

6466

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

34.7

99.2

135

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

99.2

1251

5366

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.0

98.9

615

1808

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.2

98.7

1139

4702

D19

ICPC

Teeth/gum symptom/complaint

1.4

98.6

4973

31842

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.7

97.9

300

462

R00.2

ICD-10 Finland

Palpitations

2.0

97.6

1324

5852

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

97.5

4965

31840

M65.3

ICD-10 Finland

Trigger finger

2.4

97.3

924

3479

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

97.1

4844

30936

A29

ICPC

General symptom/complaint other

1.7

96.4

2147

11265

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

95.8

759

2591

A02BX02

ATC

sucralfate; oral

2.4

95.8

897

3352

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

95.5

2344

12649

M77.0

ICD-10 Finland

Medial epicondylitis

3.3

95.3

517

1379

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

4.2

95.3

385

800

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

95.2

4123

25566

RD211

NOMESCO Finland

2.3

95.1

987

3881

R07.0

ICD-10 Finland

Pain in throat

2.2

95.0

1065

4341

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

94.8

994

3926

K08.80

ICD-10 Finland

Toothache NOS

1.9

94.8

1468

6827

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

94.8

2317

12489

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

49.5

93.8

119

M46.4

ICD-10 Finland

Discitis, unspecified

288.9

93.6

100

M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

288.9

93.6

100

SPAT1106

SPAT

Acupuncture

8.0

93.5

224

244

D02

ICPC

Abdominal pain epigastric

2.2

93.5

1061

4346

M48.8

ICD-10 Finland

Other specified spondylopathies

56.2

93.4

116

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.9

92.9

610

1860

G04BD07

ATC

tolterodine; oral

2.2

92.7

1060

4356

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

92.6

3932

24259

R55

ICD-10 Finland

Syncope and collapse

1.7

92.5

2084

10968

R03AC13

ATC

formoterol; inhalant

2.2

92.4

1025

4156

N39.3

ICD-10 Finland

Stress incontinence

1.9

92.4

1419

6577

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

92.1

2224

11938

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

92.1

1401

6469

M75.2

ICD-10 Finland

Bicipital tendinitis

3.2

92.0

530

1477

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

91.8

796

2858

S80.0

ICD-10 Finland

Contusion of knee

2.1

91.7

1194

5187

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.2

91.7

516

1415

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.7

91.3

676

2220

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.5

91.0

347

682

L04

ICPC

Chest symptom/complaint

2.1

90.9

1082

4524

R12

ICD-10 Finland

Heartburn

2.0

90.8

1324

6015

RF210

NOMESCO Finland

2.9

90.6

584

1759

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

90.4

1323

6020

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

90.3

4228

26604

M53.9

ICD-10 Finland

Dorsopathy, unspecified

12.6

90.1

170

118

M15.8

ICD-10 Finland

Other polyarthrosis

3.7

90.1

420

993

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.1

90.1

539

1543

72898

ICD-8 Finland

Vertebrogenic pain syndrome, Alia definita

+∞

89.8

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.0

89.7

555

1626

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

89.6

4689

30150

XQ800

NOMESCO Finland

Prick test

1.9

89.6

1339

6138

J45.8

ICD-10 Finland

Mixed asthma

2.8

89.5

625

1981

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

89.3

4600

29488

M41.2

ICD-10 Finland

Other idiopathic scoliosis

71.9

89.3

107

H92.0

ICD-10 Finland

Otalgia

2.3

89.3

900

3489

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

89.3

1465

6952

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.2

89.2

495

1343

NA3BG

SPAT

3.9

89.2

388

864

RF420

NOMESCO Finland

4.4

89.1

347

696

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.6

88.9

693

2345

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

88.9

780

2818

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

88.7

1619

7967

R51.81

ICD-10 Finland

Facial pain NOS

3.4

88.4

466

1217

P01

ICPC

Feeling anxious/nervous/tense

1.9

88.4

1329

6106

SGA01

NOMESCO Finland

Tooth opening as first aid

1.6

88.3

2936

17122

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

88.3

2412

13388

D07AA02

ATC

hydrocortisone; topical

1.6

88.2

2477

13847

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

88.1

1123

4834

R01AD11

ATC

triamcinolone; nasal

1.8

87.9

1759

8920

A06AC51

ATC

ispaghula, combinations; systemic

2.2

87.7

1011

4169

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.3

87.5

888

3452

J01MA14

ATC

moxifloxacin; systemic

1.8

87.5

1790

9140

J01DA06

ATC

[U] cefuroxime; systemic

1.6

87.5

2925

17083

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.5

87.4

755

2706

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.4

87.4

781

2848

SPAT1210

SPAT

Application of cast or individual aid

2.3

87.3

863

3313

R50.9

ICD-10 Finland

Fever, unspecified

1.6

87.1

2582

14635

R09

ICPC

Sinus symptom/complaint

2.0

87.1

1267

5751

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

11.8

86.3

168

125

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

85.9

2099

11294

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

85.8

1728

8779

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

85.5

1161

5125

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

85.5

1320

6122

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

85.5

1945

10250

N07BA03

ATC

varenicline; oral

2.1

85.1

1022

4290

B01AF01

ATC

rivaroxaban; oral

1.6

85.1

2368

13203

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.5

85.0

721

2557

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

84.8

4723

30682

J46

ICD-10 Finland

Status asthmaticus

2.9

84.7

544

1635

M50.2

ICD-10 Finland

Other cervical disc displacement

95.1

84.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

84.6

1259

5763

C10AC01

ATC

colestyramine; oral

2.9

84.5

560

1716

E000001

ATC

1.5

84.5

3863

24151

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

5.9

84.4

252

376

T90

ICPC

Diabetes non-insulin dependent

1.4

84.3

4768

31059

R06AE09

ATC

levocetirizine; oral

1.6

84.3

2659

15298

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

84.2

1504

7344

H57.1

ICD-10 Finland

Ocular pain

2.8

84.0

597

1914

71310

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis cervicalis

+∞

83.9

ICD-10 Finland

3.0

83.8

526

1555

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.5

83.8

704

2485

J01FA15

ATC

telithromycin; oral

1.7

83.7

2046

11009

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

11.7

83.5

163

122

A03

ICPC

Fever

1.6

83.5

2570

14694

H93.1

ICD-10 Finland

Tinnitus

1.9

83.5

1327

6222

N06AX12

ATC

bupropion; oral

2.1

83.5

982

4084

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

83.5

2914

17178

F34.1

ICD-10 Finland

Dysthymia

2.6

83.4

646

2179

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

83.3

7258

50826

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

83.3

2486

14106

S15

ICPC

Foreign body in skin

1.9

83.3

1241

5682

M89.0

ICD-10 Finland

Algoneurodystrophy

6.9

83.2

220

279

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

83.0

870

3435

C10AA04

ATC

fluvastatin; oral

1.7

82.8

1747

9002

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

82.7

1195

5406

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.2

82.6

865

3414

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.3

82.5

441

1164

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.3

82.5

444

1178

M67.4

ICD-10 Finland

Ganglion

2.0

82.5

1216

5542

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

82.5

1901

10056

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

82.4

1166

5231

N62

ICD-10 Finland

Hypertrophy of breast

2.3

82.4

800

3044

N81.6

ICD-10 Finland

Rectocele

1.9

82.4

1263

5842

XF404

NOMESCO Finland

Ambulatory ECG

1.7

82.4

1870

9845

M75.5

ICD-10 Finland

Bursitis of shoulder

3.1

82.2

481

1355

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

82.0

1591

7984

R4110

SPAT

2.8

82.0

583

1867

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

81.9

859

3391

L60.0

ICD-10 Finland

Ingrowing nail

2.3

81.8

801

3061

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

81.7

2999

17871

A02BA03

ATC

famotidine; systemic

2.3

81.6

822

3185

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

81.5

933

3836

I20.09

ICD-10 Finland

Unstable angina

2.0

81.4

1107

4891

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

3.2

81.4

467

1299

A01AB04

ATC

amphotericin B; local oral

2.1

81.3

997

4221

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

81.2

2606

15049

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

80.9

2243

12481

ZZH31

NOMESCO Finland

Bone allograft, small pieces

5.9

80.8

240

356

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.2

80.7

458

1263

G04CA01

ATC

alfuzosin; oral

1.6

80.7

2308

12949

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.4

80.6

413

1055

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

80.6

1403

6787

U07

ICPC

Urine symptom/complaint other

2.0

80.4

1099

4864

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.7

80.4

379

905

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

+∞

80.0

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.5

80.0

670

2361

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

79.6

762

2879

N07CA01

ATC

betahistine; oral

1.8

79.5

1503

7475

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.2

79.5

452

1249

RF410

NOMESCO Finland

4.4

79.3

306

609

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.7

79.3

565

1814

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

79.2

722

2660

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.8

79.1

550

1737

M41.5

ICD-10 Finland

Other secondary scoliosis

60.6

79.1

R06AX13

ATC

loratadine; oral

1.5

79.0

2732

16053

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

79.0

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

11.7

78.6

153

114

U05

ICPC

Urination problems other

2.2

78.5

883

3600

A46

ICD-10 Finland

Erysipelas

1.5

78.3

2753

16235

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

78.2

663

2352

L05

ICPC

Flank/axilla symptom/complaint

2.1

78.1

1010

4372

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

78.0

807

3165

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

78.0

R03AC12

ATC

salmeterol; inhalant

2.2

78.0

884

3617

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

77.8

8939

65007

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

77.3

848

3419

SPAT1053

SPAT

Memory test

1.5

77.0

2821

16788

N06AX26

ATC

vortioxetine; oral

2.1

76.9

911

3800

G50.1

ICD-10 Finland

Atypical facial pain

3.5

76.8

378

936

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.1

76.6

315

667

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.3

76.5

787

3080

W19

ICD-10 Finland

Unspecified fall

1.7

76.4

1730

9093

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

76.4

1526

7723

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.2

76.2

310

650

M75

ICD-10 Finland

Shoulder lesions

2.2

76.1

831

3341

L18

ICPC

Muscle pain

2.4

76.0

669

2418

M25.2

ICD-10 Finland

Flail joint

4.7

75.9

274

510

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

75.8

3268

20141

UJH02

NOMESCO Finland

Anoscopy

2.2

75.7

865

3549

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

75.4

718

2706

M05BA04

ATC

alendronic acid; oral

1.8

75.3

1539

7842

J01

ICD-10 Finland

Acute sinusitis

2.2

75.0

848

3465

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.9

74.9

503

1554

R01AD05

ATC

budesonide; nasal

1.8

74.8

1511

7673

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

74.5

2511

14652

J01AA07

ATC

tetracycline; systemic

1.5

74.3

2681

15890

H13

ICPC

Plugged feeling ear

1.5

74.1

3465

21701

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

20.9

74.1

115

71700

ICD-8 Finland

+∞

74.0

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

74.0

960

4159

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

74.0

1225

5821

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.4

73.9

379

970

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

5.1

73.8

246

420

R30.0

ICD-10 Finland

Dysuria

2.4

73.7

661

2416

SPAT1043

SPAT

Audiometry

1.6

73.6

1995

11021

TAB00

NOMESCO Finland

Lumbar puncture

2.2

73.6

807

3251

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

4.1

73.6

305

651

C03AA03

ATC

hydrochlorothiazide; oral

1.6

73.5

1939

10636

S21

ICPC

Skin texture symptom/complaint

1.6

73.2

2300

13194

C01CA24

ATC

epinephrine; parenteral

2.0

73.1

1038

4663

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.8

72.6

326

748

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

20.6

72.4

113

SPAT1104

SPAT

Monitoring of emergency patient

1.8

72.4

1288

6274

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

72.2

2296

13206

M01AC02

ATC

tenoxicam; systemic, rectal

2.0

72.1

1026

4611

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

72.0

880

3720

N06AB05

ATC

paroxetine; oral

1.9

71.7

1160

5469

L04AB04

ATC

adalimumab; parenteral

3.5

71.6

358

898

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.5

71.6

599

2110

H29

ICPC

Ear symptom/complaint other

1.6

71.6

1851

10093

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

71.4

1727

9248

C08CA05

ATC

nifedipine; systemic

1.8

71.3

1253

6078

SPAT1281

SPAT

Other administrative function

1.7

71.3

1496

7682

SPAT1131

SPAT

Colonoscopy

2.3

71.2

690

2623

SBB10

NOMESCO Finland

Teeth copy

2.0

71.1

997

4456

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

70.7

812

3340

J02AC02

ATC

itraconazole; systemic

1.4

70.5

3584

22792

M51

ICD-10 Finland

Other intervertebral disc disorders

10.6

70.4

144

119

K80

ICPC

Cardiac arrhythmia NOS

1.8

70.4

1387

6984

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

70.3

1068

4921

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

70.1

1601

8432

ZXC95

NOMESCO Finland

Use of surgical navigator

4.3

69.9

273

551

E66.8

ICD-10 Finland

Other obesity

2.0

69.8

915

3979

M53.8

ICD-10 Finland

Other specified dorsopathies

9.2

69.7

154

147

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.3

69.7

376

1001

RF120

NOMESCO Finland

4.3

69.6

273

553

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

12.3

69.0

131

L85

ICPC

Acquired deformity of spine

25.2

68.8

101

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

68.7

564

1967

UDC00

NOMESCO Finland

Ear microscopy

1.8

68.6

1384

7019

9183

FHL

Posterolateral spondylodesis

65.9

68.6

K85

ICPC

Elevated blood pressure

1.5

68.6

2888

17680

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

68.5

1663

8910

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

2.7

68.5

504

1651

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

68.3

2127

12160

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

68.3

1830

10071

N41.1

ICD-10 Finland

Chronic prostatitis

2.8

68.1

473

1495

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

68.1

1285

6382

L92

ICPC

Shoulder syndrome

2.7

68.0

485

1559

1221

FHL

Arthroscopy and meniscus surgery

2.4

67.9

635

2371

UJD02

NOMESCO Finland

Gastroscopy

2.0

67.8

921

4062

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

67.8

1143

5464

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

67.6

2331

13654

L89

ICPC

Osteoarthrosis of hip

2.3

67.5

676

2611

SPAT1284

SPAT

Extensive health certificate

2.6

67.5

532

1812

-50

ICPC

Medication/prescr/renewal

2.1

67.4

828

3508

S83.2

ICD-10 Finland

Tear of meniscus, current

1.8

67.2

1328

6690

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

67.0

981

4455

S97

ICPC

Chronic ulcer skin

1.9

67.0

1031

4769

S20.2

ICD-10 Finland

Contusion of thorax

2.0

66.9

897

3937

C10AA03

ATC

pravastatin; oral

1.7

66.6

1372

7001

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

66.6

570

2033

G04BD11

ATC

fesoterodine; oral

2.4

66.6

611

2259

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

66.4

593

2163

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

66.4

1938

10905

N06AG02

ATC

moclobemide; oral

2.0

66.2

889

3905

H02

ICPC

Hearing complaint

1.5

66.1

2266

13252

SPAT1360

SPAT

Extensive global examination

1.7

66.1

1405

7237

M04AA01

ATC

allopurinol; systemic

1.5

66.1

2478

14791

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

66.0

1930

10861

SPAT1285

SPAT

Provision of consultation response

1.9

66.0

1003

4617

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

66.0

888

3905

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

65.9

1158

5616

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

31.8

65.8

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

69.0

65.7

M23.8

ICD-10 Finland

Other internal derangements of knee

2.3

65.1

656

2540

Z01.7

ICD-10 Finland

Laboratory examination

1.6

65.0

2075

11928

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

64.9

649

2503

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.8

64.8

457

1458

WX704

NOMESCO Finland

Intubation

1.8

64.8

1277

6427

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

64.8

574

2085

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

64.8

4958

33772

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

64.7

1742

9596

S01

ICPC

Pain/tenderness of skin

2.1

64.6

773

3236

K04.0

ICD-10 Finland

Pulpitis

1.7

64.4

1594

8584

M19.2

ICD-10 Finland

Other secondary arthrosis

3.8

64.3

292

677

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.5

64.3

2520

15179

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

64.2

3464

22234

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

64.2

1200

5938

VALMI

NOMESCO Finland

1.4

64.1

4413

29551

SPAT1255

SPAT

Intravenous administration of medicine

1.8

63.8

1234

6170

R10.0

ICD-10 Finland

Acute abdomen

2.4

63.8

570

2080

B01AX06

ATC

[U] rivaroxaban; oral

2.6

63.7

484

1614

ZA1.0

ICD-10 Finland

Shoulder region

2.8

63.5

449

1435

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

49.8

63.4

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

+∞

63.2

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.3

63.0

608

2306

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.7

62.9

450

1449

D12

ICPC

Constipation

2.3

62.4

595

2244

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

62.4

1601

8701

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

62.3

4889

33396

R33

ICD-10 Finland

Retention of urine

1.7

62.2

1415

7433

NA2AD

NOMESCO Finland

Thoracic spine CT examination

8.1

62.2

147

158

SPAT1252

SPAT

Overall medication plan or its review

1.7

62.0

1290

6601

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

61.7

1072

5175

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.6

61.6

1733

9649

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

61.6

619

2395

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

61.6

1808

10179

A05

ICPC

Feeling ill

2.0

61.5

795

3439

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

8.4

61.5

142

147

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

61.4

1086

5273

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.4

61.3

541

1959

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

61.3

965

4499

S04

ICPC

Lump/swelling localized

1.6

61.3

1579

8591

N30

ICD-10 Finland

Cystitis

1.7

61.2

1248

6346

M20.2

ICD-10 Finland

Hallux rigidus

2.2

61.2

640

2522

R49.01

ICD-10 Finland

Functional dysphonia

2.4

61.2

573

2142

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

61.0

625

2440

M01AB16

ATC

aceclofenac; oral

2.2

60.9

673

2720

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

60.9

1237

6281

L04AB01

ATC

etanercept; parenteral

3.7

60.8

281

662

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

2.7

60.7

444

1448

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

60.7

610

2359

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

17.6

60.4

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

60.4

1028

4927

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

60.4

737

3112

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

60.3

1466

7849

C08DA01

ATC

verapamil; systemic

2.0

60.2

780

3375

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

60.0

406

1262

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

59.5

578

2200

S70.0

ICD-10 Finland

Contusion of hip

2.2

59.5

625

2469

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

59.4

978

4635

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

59.3

909

4199

72820

ICD-8 Finland

Vertebrogenic pain syndrome, Diffuse syndrome cerviocobrachial

+∞

59.2

A97

ICPC

No disease

1.5

59.1

2617

16152

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

59.1

705

2949

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

58.9

552

2063

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.1

58.8

695

2894

35399

ICD-8 Finland

Sciatica

5.4

58.7

187

304

A10BA02

ATC

metformin; oral

1.3

58.6

5596

39287

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

530.5

58.5

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.3

58.4

308

807

TAC00

NOMESCO Finland

Peripheral nerve block

8.7

58.4

132

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

58.3

720

3055

J05AB11

ATC

valaciclovir; oral

1.5

58.3

2396

14560

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

58.3

1424

7631

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

58.3

4210

28354

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.1

58.3

696

2911

Z56.5

ICD-10 Finland

Uncongenial work

24.2

58.0

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

58.0

1705

9595

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

58.0

1165

5897

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.9

57.9

952

4510

P20

ICPC

Memory disturbance

1.5

57.8

2097

12401

R06AX26

ATC

fexofenadine; oral

1.8

57.7

1166

5911

R29

ICPC

Respiratory symptom/complaint other

1.8

57.5

1083

5369

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

139.5

57.4

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.4

57.3

300

782

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.4

57.1

218

431

SPAT1283

SPAT

Restricted health certificate

1.5

57.1

2364

14387

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.8

56.9

393

1238

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.9

56.9

250

564

L20

ICPC

Joint symptom/complaint NOS

2.2

56.9

610

2433

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

56.8

1025

5009

N07BC02

ATC

methadone; systemic

11.7

56.8

110

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

56.7

2372

14460

J01FA01

ATC

erythromycin; systemic

1.5

56.7

2274

13746

K03.00

ICD-10 Finland

Approximal wear

1.9

56.7

897

4191

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

2.5

56.4

467

1636

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

56.2

1898

11039

R06.2

ICD-10 Finland

Wheezing

2.0

56.1

750

3288

L99

ICPC

Musculoskeletal disease other

2.9

56.1

366

1113

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

56.1

931

4424

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

56.1

3951

26480

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

12.3

56.1

106

TQW40

SPAT

2.2

56.0

619

2504

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

55.9

829

3780

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

10.0

55.9

117

102

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

4.4

55.8

215

429

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.6

55.8

205

390

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

20.8

55.5

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

55.5

896

4216

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

55.5

2395

14693

72830

ICD-8 Finland

Vertebrogenic pain syndrome, Radicular syndrome of upper limbs

+∞

55.3

G54.2

ICD-10 Finland

Cervical root disorders, not elsewhere classified

18.5

55.3

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

55.1

1384

7470

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

54.9

1007

4947

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

54.7

442

1527

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.4

54.6

480

1736

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

54.6

1700

9699

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

2.5

54.6

453

1590

N03A

ATC

ANTIEPILEPTICS

19.0

54.5

G03DB01

ATC

dydrogesterone; oral

1.5

54.5

2196

13282

A08

ICPC

Swelling

2.0

54.4

741

3272

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

54.4

1859

10841

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

54.3

1709

9775

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

43.6

54.2

SPAT1377

SPAT

Polysomnography

2.1

54.2

673

2861

-69

ICPC

Other reason for encounter NEC

2.0

54.1

739

3267

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.4

54.0

488

1792

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

54.0

2445

15142

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

3.6

53.9

263

649

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.0

53.9

334

983

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.5

53.9

2025

12066

N03AX11

ATC

topiramate; oral

2.7

53.8

398

1307

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

53.8

1193

6214

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

53.8

3069

19844

M42.0

ICD-10 Finland

Juvenile osteochondrosis of spine

53.1

53.8

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.0

53.7

729

3214

E000006

ATC

1.7

53.7

1277

6788

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

53.7

886

4200

M22.4

ICD-10 Finland

Chondromalacia patellae

2.4

53.7

503

1881

N29

ICPC

Neurological sympt/complt other

2.7

53.6

379

1213

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

53.6

1888

11086

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

53.5

2314

14196

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

4.7

53.5

192

357

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.6

53.4

421

1435

D07AB08

ATC

desonide; topical

1.5

53.4

1892

11126

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.3

53.4

507

1910

WZC00

SPAT

2.0

53.3

717

3152

D01BA02

ATC

terbinafine; oral; topical

1.3

53.2

5060

35428

J01DA08

ATC

[U] cefaclor; oral

1.6

53.0

1556

8748

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.3

53.0

516

1967

F32

ICD-10 Finland

Depressive episode

1.9

52.9

795

3643

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.6

52.9

1600

9061

N06AA06

ATC

trimipramine; systemic

2.4

52.8

485

1795

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.1

52.7

619

2571

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

52.7

847

3978

R03BB01

ATC

ipratropium bromide; inhalant

2.0

52.7

706

3097

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

52.7

637

2679

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

52.6

708

3112

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3019069) Monocytes/100 leukocytes in Blood

13528

87695

1.62

322.40

6.7

6.1

8.7

0.69

12718

81961

(3006504) Eosinophils/100 leukocytes in Blood

13466

87236

1.62

321.44

6.5

5.9

2.9

3.96

12609

81144

(3022096) Basophils/100 leukocytes in Blood

13140

84653

1.62

320.53

6.5

5.9

0.7

1.20

12293

78806

(40761511) CBC panel - Blood by Automated count

26019

202118

2.37

319.31

17.5

12.7

—

(3033658) Prothrombin time (PT) actual/Normal

8472

48892

1.69

317.91

3.9

4.0

92.0

89.4

18.15

8183

47798

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6413

34293

1.78

315.38

2.8

3.2

mmol/l

2.5

2.73

5594

29960

(3002030) Lymphocytes/100 leukocytes in Blood

13748

90003

1.61

309.98

6.6

5.9

27.9

27.4

6.47

12857

83632

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10559

56935

1.94

307.65

2.7

2.5

u/l

56.3

60.0

7.37

9736

52351

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6766

35764

1.82

307.65

1.3

1.2

u/ml

1.3

1.9

5.66

2027

9425

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9597

54023

1.79

307.65

3.0

2.9

ng/l

1069.7

1516.2

25.31

8253

46254

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7968

44677

1.74

307.65

2.4

2.2

mg/l

3.0

0.65

6903

37870

(36304419) Bacteria [Presence] in Urine

9280

50147

1.88

307.65

3.5

3.0

—

(3001604) Monocytes [#/volume] in Blood

15048

91423

1.88

307.65

6.2

5.7

e9/l

0.6

2.39

13219

78100

(3018418) pH of Serum or Plasma

10130

55324

1.89

307.65

4.0

4.2

7.4

0.12

2256

10940

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14112

84991

1.85

307.65

5.8

6.0

mmol/l

1.2

0.82

12958

76743

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11933

68801

1.85

307.65

4.9

3.5

—

(3013115) Eosinophils [#/volume] in Blood

15445

94935

1.87

307.65

6.4

5.9

e9/l

0.2

5.82

13802

82291

(3013707) Erythrocyte sedimentation rate by Westergren method

21898

138162

2.61

307.65

5.2

3.7

mm/h

12.3

12.7

4.33

20570

126939

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15695

99156

1.81

307.65

5.6

6.5

umol/l

10.5

11.9

42.45

14886

94053

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

15531

94126

1.93

307.65

6.3

6.7

mmol/l

1.2

0.41

12919

78703

(3030467) Casts [#/volume] in Urine by Automated count

9577

51866

1.88

307.65

3.5

3.0

e6/l

0.4

0.5

3.31

7602

38332

(3019550) Sodium [Moles/volume] in Serum or Plasma

26435

202827

2.92

307.65

21.0

15.6

mmol/l

139.6

139.7

23.14

26079

197290

(40768797) Stomach Pathology biopsy report

5262

24949

1.99

307.65

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

5092

22908

2.11

307.65

1.4

1.3

titre

540.3

549.6

0.11

1020

4840

(3023103) Potassium [Moles/volume] in Serum or Plasma

26461

203503

2.91

307.65

21.1

15.7

mmol/l

4.0

14.05

26092

197602

(3044640) Blood type and Crossmatch panel - Blood

10100

58624

1.74

307.65

2.5

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

18068

110407

2.13

307.65

4.9

4.6

mmol/l

6.6

6.8

27.31

17315

103430

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

22167

148432

2.32

307.65

7.9

7.5

u/l

76.7

79.8

16.30

21032

139354

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21178

143810

2.06

307.65

4.6

3.8

pmol/l

14.9

14.8

2.66

19436

130144

(3006315) Basophils [#/volume] in Blood

15094

91894

1.88

307.65

6.2

5.7

e9/l

0.0

1.64

13256

78513

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25857

192238

2.88

307.65

18.9

13.4

mg/l

21.9

25.3

51.87

21799

150575

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

24024

175757

2.17

307.65

5.6

4.5

mu/l

1.8

2.2

10.48

22266

159654

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12243

75843

1.68

307.65

2.5

2.2

nmol/l

78.8

77.9

2.56

11045

67683

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14629

85830

1.96

307.65

4.4

3.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

16782

107461

1.84

307.65

8.6

9.3

e9/l

4.2

4.1

2.02

14944

93022

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12487

70789

1.92

307.65

4.3

3.3

ng/l

81.7

65.9

0.18

8957

48868

(3002582) Erythrocytes [#/volume] in Urine

10086

56917

1.81

307.65

3.6

3.1

e6/l

73.1

102.0

1.47

8115

42992

(3044889) 12 lead EKG panel

20478

138243

1.99

307.65

4.6

3.6

—

(3021589) Normoblasts [#/volume] in Blood

13755

84624

1.77

307.65

11.5

9.4

e9/l

0.0

0.21

11703

68906

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12110

75474

1.66

307.65

3.1

2.7

ug/l

132.8

146.4

4.18

11101

69580

(3026008) Bacteria identified in Urine by Culture

9521

53458

1.80

307.65

3.7

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

9222

46872

2.02

307.65

5.0

3.7

estimate

0.0

0.46

3449

15881

(3026493) Urate [Moles/volume] in Serum or Plasma

8879

50395

1.75

307.65

2.6

umol/l

3844.7

5074.7

2.10

7641

43769

(3021601) Nitrite [Presence] in Urine by Test strip

15257

89407

2.01

307.65

5.8

4.6

estimate

0.0

0.08

3548

16707

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7360

38394

1.87

307.65

1.8

1.7

mg/l

1.0

1.3

16.16

5702

29778

(3037467) Urinalysis macro (dipstick) panel - Urine

19473

127758

2.00

307.65

5.2

4.0

—

(3009261) Glucose [Presence] in Urine by Test strip

15385

90377

2.01

307.65

4.6

3.4

estimate

0.0

0.01

3449

16195

(3000850) Epithelial cells [#/volume] in Urine

7681

38271

1.99

307.65

2.8

2.6

e6/l

5.2

5.3

0.40

6757

33253

(3019198) Lymphocytes [#/volume] in Blood

15297

94131

1.86

307.65

6.3

5.7

e9/l

2.0

1.9

1.45

13709

81836

(3015377) Calcium [Moles/volume] in Serum or Plasma

10723

63869

1.71

307.65

2.9

3.6

mmol/l

2.4

0.22

9482

55616

(40760892) CBC W Ordered Manual Differential panel - Blood

7369

39472

1.81

307.65

4.9

4.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12603

77481

1.71

307.65

2.2

1.9

pmol/l

96.1

95.6

0.49

6535

40299

(3032080) INR in Blood by Coagulation assay

12698

78189

1.71

307.65

9.5

9.0

inr

1.2

1.3

9.02

4478

22078

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10893

54959

2.14

307.65

2.4

2.0

u/l

188.5

219.9

2.66

10194

51372

(3018095) Leukocytes [#/volume] in Urine

11427

65733

1.83

307.65

4.2

3.5

e6/l

89.5

111.5

1.37

8738

46097

(3026782) Osmolality of Urine

6890

36586

1.81

307.65

3.0

2.7

mosm/kgh2o

525.2

552.0

20.22

5911

31018

(3035350) Ketones [Presence] in Urine by Test strip

15264

88933

2.03

307.65

4.5

3.3

estimate

0.0

0.14

3497

16420

(3019150) Specific gravity of Urine by Refractometry

6855

36527

1.81

307.65

5.2

3.7

kg/l

1.0

0.50

1104

5785

(3031040) Bacteria [#/volume] in Urine by Automated count

18966

120319

2.08

307.65

5.7

4.0

e6/l

1225.7

1444.7

0.16

209

1823

(3011397) Hemoglobin [Presence] in Urine by Test strip

7613

40527

1.84

307.65

4.4

3.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6494

26325

2.45

307.65

1.3

1.2

u/ml

10.2

14.6

2.99

2676

10083

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

24200

181891

2.00

307.65

6.7

5.7

mmol/mol

40.2

40.0

4.48

22649

167348

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6826

28155

2.42

307.65

1.4

1.2

iu/ml

30.8

44.9

4.87

2099

9174

(3024561) Albumin [Mass/volume] in Serum or Plasma

13521

82170

1.79

307.65

4.3

4.9

g/l

35.7

35.2

24.28

12544

76127

(3021960) Folate [Moles/volume] in Serum or Plasma

7549

42650

1.71

303.74

1.6

1.5

nmol/l

20.7

20.3

1.22

6536

36351

(3018010) Neutrophils/100 leukocytes in Blood

13531

88538

1.60

303.16

6.4

5.7

57.0

57.7

7.96

12690

82647

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

24879

191086

2.00

293.06

5.3

4.5

mmol/l

6.0

5.47

22855

173884

(42870588) Differential panel, method unspecified - Blood

10285

63428

1.62

291.45

6.1

5.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

6310

34278

1.75

290.28

1.9

1.7

nmol/l

1255.5

1147.8

16.23

4838

25626

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7061

39756

1.70

284.42

1.8

1.7

pmol/l

22481332.6

31823213.9

0.83

5756

32615

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4107

19711

1.92

281.85

3.8

3.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

24352

186568

1.88

274.35

16.9

13.0

ml/min/173m2

79.1

79.2

0.24

21222

153536

(3048689) Calprotectin [Mass/mass] in Stool

3992

19203

1.91

271.21

2.1

2.2

ug/g

131.2

143.8

1.35

3134

15057

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1742

6101

2.54

261.00

1.3

1.2

u/ml

1.1

1.0

0.21

192

442

(40761535) Cells panel - Urine sediment

3075

13800

2.02

254.26

4.0

3.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3287

15105

1.98

254.25

2.2

2.4

nmol/l

348.6

381.2

15.42

3013

13962

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7564

44532

1.62

250.44

2.5

2.3

—

(3042936) Bacteria identified in Isolate by Culture

4916

25799

1.77

250.33

2.2

2.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5784

31848

1.70

247.83

3.0

2.7

e6/l

1.1

1.2

0.95

3643

17669

(3002385) Erythrocyte distribution width [Ratio]

21494

160405

1.63

245.91

21.7

16.6

13.8

13.7

6.44

21160

156667

(3007853) Bacteria identified in Skin by Aerobe culture

4147

20799

1.83

245.16

1.9

1.7

—

(40758558) Short blood count panel - Blood

7900

47373

1.60

240.55

6.3

7.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

5770

31984

1.69

240.12

1.5

1.4

g/l

2.4

2.5

3.72

3473

19376

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26374

209463

2.26

240.08

12.8

10.0

u/l

26.3

26.5

1.53

25674

201557

(3023368) Bacteria identified in Blood by Culture

8392

51321

1.57

233.50

4.8

4.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2718

12094

2.03

228.82

2.1

2.3

—

(3008898) HLA-B27 [Presence]

1258

4034

2.75

223.87

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

8029

49259

1.56

216.82

4.2

3.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3843

19713

1.78

207.90

1.8

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5203

29089

1.65

205.38

1.9

1.8

—

(3025159) Blasts/100 leukocytes in Blood

2942

13963

1.90

204.17

4.0

4.1

0.3

0.2

0.17

618

3633

(3020630) Protein [Mass/volume] in Serum or Plasma

3097

14963

1.87

203.38

2.2

2.5

g/l

66.8

66.3

3.69

2815

13622

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3814

19714

1.76

200.40

1.8

1.7

—

(40761536) Microorganisms panel - Urine sediment

3228

15894

1.84

199.38

4.8

3.7

—

(3017181) Myelocytes/100 leukocytes in Blood

3195

15686

1.84

199.17

4.0

4.1

0.9

1.0

0.90

798

4606

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2518

11432

1.98

198.96

2.5

2.3

au/ml

36.7

23.7

2.25

711

(3021440) Promyelocytes/100 leukocytes in Blood

3066

14930

1.85

195.98

4.0

4.1

0.1

0.86

728

4291

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3137

15403

1.84

195.24

2.6

2.2

ug/l

5.2

8.3

19.98

2782

13432

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

25266

199790

1.82

194.92

5.7

4.9

mmol/l

2.7

2.8

27.64

23394

183429

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3223

15971

1.82

194.70

3.7

3.9

mmol/l

1.2

0.51

2805

13943

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5398

30931

1.61

191.39

2.9

3.5

mmol/l

0.8

0.19

4968

28898

(3007461) Platelets [#/volume] in Blood

26858

217322

2.29

186.53

27.7

19.8

e9/l

252.1

249.1

11.68

26457

210716

(3010813) Leukocytes [#/volume] in Blood

26867

217534

2.29

184.13

27.7

19.8

e9/l

6.9

6.7

20.63

26410

210178

(3035941) MCH [Entitic mass]

26859

217458

2.28

183.79

27.6

19.7

30.5

30.3

28.74

26629

213896

(3002179) Metamyelocytes/100 leukocytes in Blood

2907

14207

1.84

182.95

3.8

3.9

0.5

0.7

3.19

588

3350

(3024731) MCV [Entitic volume]

26859

217499

2.28

182.89

27.6

19.7

91.7

91.2

77.87

26628

213926

(3026361) Erythrocytes [#/volume] in Blood

26860

217513

2.28

182.84

27.7

19.8

e12/l

4.4

4.5

63.79

26411

210115

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2284

10319

1.98

182.33

1.3

au/ml

61.2

50.2

0.95

509

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3970

21260

1.70

182.31

6.1

7.7

kpa

5.2

5.1

5.03

3808

20314

(3027801) Oxygen [Partial pressure] in Arterial blood

3968

21247

1.70

182.29

6.1

7.7

kpa

12.4

12.5

0.45

3806

20291

(3000963) Hemoglobin [Mass/volume] in Blood

26861

217570

2.27

181.84

27.8

19.9

g/l

134.6

135.8

34.50

26638

214029

(3003396) Base excess in Arterial blood by calculation

3948

21285

1.69

176.29

6.1

7.7

mmol/l

1.2

1.0

2.67

3177

16913

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17297

126962

1.44

173.61

3.5

3.0

u/l

53.1

51.0

1.76

16026

117937

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2956

14761

1.80

172.82

2.6

2.7

ml/min/173m2

65.8

64.0

1.59

1203

5761

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6034

36239

1.54

172.12

4.3

3.5

ng/l

202.5

614.7

17.19

4728

28807

(3022948) Iron [Moles/volume] in Serum or Plasma

5117

29671

1.59

170.08

2.4

2.5

umol/l

13.0

12.9

0.07

4713

27474

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24748

195924

1.69

169.00

5.1

4.4

mmol/l

4.6

4.7

21.14

23011

180836

(3009508) Creatinine [Moles/volume] in Urine

9265

60939

1.45

168.45

3.1

3.2

mmol/l

7.4

7.6

1.67

7718

50875

(3016502) Oxygen saturation in Arterial blood

3562

18898

1.71

168.18

6.3

8.2

95.8

95.5

1.83

3450

18232

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9355

61813

1.45

165.16

3.1

3.2

u/l

32.3

35.0

2.85

8791

58491

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24552

194457

1.65

160.46

5.0

4.4

mmol/l

1.5

9.29

22667

178577

(3000494) Fungus identified in Specimen by Culture

3884

21408

1.64

157.75

1.5

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3303

17471

1.70

156.90

6.7

8.6

g/l

122.2

121.0

2.85

3212

16873

(3020682) Albumin/Creatinine [Ratio] in Urine

9344

62361

1.43

153.19

3.9

4.0

mg/mmol

8.3

8.9

0.49

5828

39209

(3012516) Albumin [Mass/volume] in Urine

8899

58956

1.43

151.54

3.2

mg/l

465.8

315.7

2.03

5682

36872

(3005322) IgE [Units/volume] in Serum or Plasma

2127

10012

1.89

149.17

1.4

1.3

u/ml

199.9

282.2

3.20

1974

9274

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2563

12810

1.79

148.15

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5070

30196

1.54

147.04

3.3

2.8

e6/l

2.8

2.5

1.01

2957

16105

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4008

22623

1.61

146.92

8.5

6.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23808

188012

1.56

146.57

4.5

3.9

mmol/l

1.4

1.3

46.73

21816

171521

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4697

27565

1.55

145.43

2.4

2.5

g/l

2.4

2.3

8.28

4299

25428

(4010399)

2537

12739

1.78

144.16

1.5

1.4

—

(3019060) Gas panel - Arterial blood

2365

11660

1.81

142.84

4.1

5.0

—

(3025941) Bacteria identified in Stool by Culture

2026

9544

1.88

141.47

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4373

25402

1.56

141.25

1.5

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4415

25774

1.56

139.30

2.5

2.6

22.2

22.8

1.86

3820

22126

(3013139) Helicobacter pylori Ag [Presence] in Stool

2341

11601

1.80

138.83

1.3

1.2

—

(3022145) Colonoscopy Study observation

3789

21406

1.60

137.57

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2369

11850

1.78

136.01

7.3

9.9

93.9

0.17

2359

11808

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1246

5004

2.19

135.09

1.5

1.4

ug/g

278.6

264.1

1.60

728

2942

(3022217) INR in Platelet poor plasma by Coagulation assay

4278

25029

1.55

133.03

24.3

24.9

inr

1.3

1.4

4.18

564

3534

(3020891) Body temperature

1562

6888

2.00

132.23

4.6

4.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3048

16499

1.65

131.06

5.9

7.4

mmol/l

1.3

1.4

1.94

2950

15911

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4848

29263

1.51

130.11

2.0

2.1

29.9

0.04

4726

28426

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2341

11824

1.76

129.73

7.3

9.7

1.4

1.3

3.69

2323

11750

(3014576) Chloride [Moles/volume] in Serum or Plasma

4123

24102

1.55

128.23

6.4

7.4

mmol/l

104.2

104.5

4.07

4050

23596

(3005719) IgG [Mass/volume] in Serum or Plasma

2524

13086

1.72

127.40

2.7

g/l

10.1

10.7

10.89

2295

11961

(40768804) Tissue Pathology biopsy report

11316

79874

1.36

124.91

2.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2316

11818

1.74

123.58

7.4

9.8

0.7

7.18

2300

11749

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2256

11546

1.73

118.92

5.8

7.4

mmol/l

25.0

24.7

2.33

2239

11432

(3013512) EKG study

8442

57208

1.38

118.86

4.4

3.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1128

4610

2.14

116.80

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1385

6119

1.99

116.31

4.0

4.3

mmol/l

1.3

1.4

0.95

1360

6017

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

543

1571

3.00

116.01

1.5

31.3

30.2

0.25

318

993

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2161

11031

1.74

114.81

6.5

7.3

mmol/l

24.9

24.5

5.80

2028

10289

(3021788) Differential panel - Synovial fluid

855

3149

2.37

113.49

1.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4131

24749

1.51

113.21

4.6

6.0

mmol/l

1.0

0.09

3833

23059

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

352

791

3.85

111.35

1.4

u/l

5.3

6.7

2.45

305

666

(3000475) Leukocytes [#/volume] in Synovial fluid

1005

4021

2.19

109.70

1.7

1.6

e6/l

12301.1

14506.4

0.89

733

2891

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1941

9743

1.76

109.17

2.5

2.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1109

4623

2.10

109.01

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

1614

7666

1.85

108.98

2.0

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

14952

111401

1.32

107.91

2.7

2.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

1114

4674

2.09

107.63

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7699

52066

1.37

107.30

1.7

1.6

mmol/l

1.4

12.54

6154

43319

(3014765) Yersinia sp identified in Stool by Organism specific culture

1110

4660

2.09

107.07

1.2

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3603

21199

1.52

107.03

2.3

2.5

1.8

0.37

3185

18734

(3043409) Potassium [Moles/volume] in Arterial blood

1201

5208

2.02

106.11

4.2

4.6

mmol/l

3.9

0.59

1152

4856

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3040

17270

1.57

105.67

2.6

2.4

u/l

40.3

48.7

0.63

2547

14847

(3023520) Reticulocytes [#/volume] in Blood

2802

15685

1.59

103.63

2.4

2.6

e9/l

69.6

69.0

0.34

2115

11754

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1144

4961

2.02

101.00

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

841

3263

2.25

98.86

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1505

7242

1.83

97.21

1.1

titre

173.3

244.6

0.30

202

(3044941) Cell count panel - Synovial fluid

707

2588

2.38

95.07

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2466

13674

1.60

94.44

3.3

4.0

ng/l

81.7

95.4

12.70

2096

11706

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1455

7007

1.82

93.66

2.0

2.2

g/l

7.4

0.14

1084

5257

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1158

5178

1.96

93.63

1.6

g/l

1.2

1.00

1103

4924

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1452

7000

1.82

93.13

2.0

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1449

6982

1.82

93.10

2.0

2.2

g/l

3.7

3.9

4.04

1044

5020

(3010421) pH of Blood

1129

5014

1.97

93.09

3.7

4.0

7.4

0.35

975

4270

(3000492) Spirometry study

2992

17436

1.53

91.91

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1124

5015

1.96

91.43

1.6

g/l

0.2

0.29

1064

4745

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1223

5655

1.89

89.43

1.8

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3529

21443

1.47

88.18

2.6

2.8

umol/l

6.8

9.6

13.60

2965

18741

(3000991) Gas panel - Venous blood

2752

15906

1.54

87.55

7.0

8.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1928

10258

1.66

86.93

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

958

4112

2.03

86.87

2.6

16.2

16.3

0.43

492

2122

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1356

6560

1.81

85.86

2.0

2.2

g/l

9.8

10.4

5.72

1137

5501

(3024354) Oxygen [Partial pressure] in Venous blood

2475

14049

1.56

85.28

3.1

kpa

4.5

4.6

2.70

2402

13586

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1356

6576

1.81

85.16

2.1

2.2

g/l

3.0

3.1

3.11

1063

5146

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1565

7963

1.73

83.27

1.3

1.6

u/ml

14.4

17.2

0.40

234

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

810

3323

2.12

82.82

1.3

1.2

u/ml

46.8

44.2

0.16

347

(3012501) Base excess in Blood by calculation

990

4375

1.97

82.70

3.7

4.0

mmol/l

2.3

2.6

2.25

714

3008

(3013290) Carbon dioxide [Partial pressure] in Blood

990

4377

1.97

82.59

3.7

4.0

kpa

5.0

1.55

974

4268

(3027315) Oxygen [Partial pressure] in Blood

994

4402

1.97

82.53

3.7

4.1

kpa

8.6

8.5

0.08

978

4293

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

849

3555

2.08

82.28

1.4

e6/l

33.9

34.8

0.02

683

2693

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

848

3557

2.08

81.80

1.4

e6/l

1168.4

2324.8

0.88

728

2841

(3028271) Lactate [Moles/volume] in Capillary blood

750

3025

2.16

80.08

2.0

1.9

mmol/l

1.7

1.8

1.81

734

2949

(3028026) IgM [Mass/volume] in Serum or Plasma

1910

10346

1.63

80.00

1.8

1.9

g/l

1.2

1.4

2.26

1739

9412

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2909

17345

1.49

79.33

3.4

3.8

kpa

5.9

5.8

4.74

2838

16858

(3022621) pH of Urine by Test strip

2121

11841

1.58

78.28

3.4

2.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

312

821

3.28

78.15

1.5

4.4

3.5

0.27

191

(3002032) Base excess in Venous blood by calculation

2895

17315

1.48

77.64

3.5

3.8

mmol/l

2.2

1.8

4.93

2405

14214

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

580

2128

2.37

77.59

1.6

1.5

56.6

58.0

0.29

327

1379

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1234

5987

1.80

77.26

2.3

g/l

0.8

0.9

0.40

1066

5097

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

912

4022

1.98

76.60

1.4

1.3

mg/l

597.0

569.1

0.25

881

3834

(3012544) pH of Venous blood

2986

18029

1.47

76.26

3.4

3.9

7.4

0.01

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1053

4892

1.88

75.74

1.6

iu/ml

21.4

6.3

0.54

256

1001

(3004716) Salmonella sp identified in Stool by Organism specific culture

1491

7683

1.70

75.60

1.3

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1008

4621

1.90

75.52

1.3

1.2

u/ml

26.2

41.9

1.19

283

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1972

10946

1.59

74.46

3.1

3.4

pmol/l

4.4

1.49

1738

9770

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1114

5298

1.84

74.41

2.2

g/l

0.0

0.05

1018

4812

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3091

18886

1.45

74.08

1.6

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

684

2749

2.16

73.69

1.3

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1245

6165

1.77

72.69

1.6

titre

258.0

288.3

0.14

264

(4034850)

1160

5664

1.79

71.02

11.1

9.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1102

5299

1.82

70.99

1.7

—

(1616796) Gas panel - Central venous blood

944

4331

1.90

70.53

3.4

3.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

612

2404

2.21

69.78

1.9

1.8

89.7

89.4

0.84

602

2372

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1583

8495

1.63

68.54

2.7

2.8

1.3

1.2

3.70

1575

8450

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1921

10809

1.56

68.18

1.8

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1555

8330

1.64

67.79

2.7

0.7

0.32

1478

8031

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1121

5510

1.78

67.07

2.1

g/l

38.2

37.4

3.97

976

4687

(3014051) Protein [Presence] in Urine by Test strip

841

3775

1.94

67.06

2.3

2.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1030

4945

1.82

66.66

2.2

g/l

0.0

0.28

936

4477

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1019

4883

1.82

66.35

2.2

g/l

0.0

0.00

933

4468

(3026389) Candida sp identified in Specimen by Organism specific culture

582

2290

2.20

66.10

1.4

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

799

3542

1.96

66.07

1.3

1.2

mmol/l

3.8

0.23

756

3327

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1267

6484

1.71

65.73

1.1

u/ml

4.1

5.3

0.13

103

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

918

4276

1.87

65.43

1.3

1.2

u/ml

5.7

7.4

0.46

135

690

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1846

10405

1.56

64.92

7.5

9.8

mmol/l

24.5

24.3

1.86

1716

9763

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3462

22090

1.39

64.41

3.6

4.4

u/l

238.1

245.9

2.76

3255

20958

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3345

21256

1.40

63.71

1.9

1.7

1.6

1.5

10.03

2844

18627

(3039162) Centromere protein B Ab [Units/volume] in Serum

538

2085

2.24

63.40

1.3

1.2

u/ml

39.8

58.0

0.85

128

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

902

4230

1.86

62.93

1.3

1.2

u/ml

4.9

5.5

0.11

448

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1244

6419

1.69

62.56

2.2

2.3

ug/l

396.9

609.8

1.86

1165

6061

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1523

8294

1.61

61.99

4.0

3.9

48.3

47.3

0.88

1510

8197

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1408

7535

1.63

61.51

1.7

2.0

u/l

39.6

39.1

0.38

1252

6600

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

782

3534

1.92

61.11

1.2

u/ml

7.4

9.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

913

4338

1.83

61.08

2.8

3.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1155

5882

1.71

60.94

2.9

3.2

mg/l

174.3

56.1

0.90

857

4750

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1152

5870

1.71

60.66

2.9

3.2

mg/l

36.8

44.0

0.65

853

4741

(21494755) Public health laboratory ask at order entry panel

1371

18225

0.63

59.55

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

779

3547

1.91

59.52

1.3

1.2

u/ml

4.3

6.1

0.44

271

(3004119) Hemoglobin [Mass/volume] in Venous blood

1938

11292

1.51

58.29

3.1

3.3

g/l

129.8

128.6

1.38

1885

11056

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1115

5713

1.70

57.50

2.8

3.1

ratio

2.0

6.3

1.66

417

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

581

2453

2.05

55.08

1.2

1.3

nmol/l

2.1

1.8

0.05

551

2366

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

544

2244

2.10

54.86

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2538

15761

1.42

54.68

2.9

2.8

ng/l

161.7

222.2

13.73

2317

14381

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

579

2452

2.05

54.44

1.2

1.3

nmol/l

0.3

0.08

175

(3023419) Bacteria identified in Sputum by Culture

539

2242

2.08

53.18

2.3

2.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1429

7947

1.57

53.06

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

755

3541

1.85

52.64

1.2

1.3

titre

192.0

110.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

746

3491

1.85

52.38

2.7

3.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1058

5519

1.67

50.96

3.4

3.3

—

(3000330) Specific gravity of Urine by Test strip

1635

9519

1.50

49.14

3.8

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

978

5048

1.69

49.03

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

312

1065

2.53

48.92

2.1

1.9

ug/l

4.0

3.6

0.27

277

949

(3028626) Oxygen [Partial pressure] in Capillary blood

823

4071

1.76

48.10

2.8

2.9

kpa

8.0

8.1

0.23

777

3757

(36660697) Celiac disease serology panel - Serum

2121

13060

1.42

47.64

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3385

22488

1.33

47.46

1.5

1.7

—

(3025577) Chromium [Mass/volume] in Blood

302

1038

2.51

46.70

2.1

2.0

ug/l

2.3

0.07

262

871

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

153

355

3.71

46.54

1.3

—

(3003338) MCHC [Mass/volume]

20292

163835

1.22

45.99

24.4

17.3

g/l

331.9

332.2

5.33

20171

162517

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

271

890

2.63

45.99

1.1

nmol/l

3.6

7.9

1.02

191

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1411

17688

0.67

45.76

1.8

—

(3021901) Oxygen saturation in Capillary blood

722

3505

1.79

45.00

2.8

2.9

—

(3044290) Cell count panel - Cerebral spinal fluid

706

3406

1.80

44.93

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1559

9164

1.49

44.61

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

472

3.25

44.26

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1665

9948

1.46

43.85

2.7

e6/l

0.3

0.77

1622

9685

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1178

6557

1.56

43.46

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

385

1532

2.17

42.66

1.4

e6/l

91913.4

124105.1

0.53

298

1037

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1708

10347

1.44

41.77

1.8

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1811

11109

1.43

41.36

1.2

iu/ml

126.7

152.5

2.22

726

4165

(3027273) Bicarbonate [Moles/volume] in Venous blood

1528

9081

1.47

41.31

3.2

3.4

mmol/l

25.5

25.2

3.38

1481

8837

(3017315) Amylase [Enzymatic activity/volume] in Urine

245

809

2.61

41.18

1.3

1.2

u/l

179.4

410.2

3.15

228

753

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1481

8770

1.47

40.78

3.6

4.2

mmol/l

24.4

24.1

2.72

1285

7954

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1308

7555

1.51

40.71

2.0

1.9

ug/l

2.3

0.02

1154

6676

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

542

2489

1.88

40.42

2.1

2.2

32.8

32.7

0.43

535

2473

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

808

4184

1.68

40.01

1.2

1.1

—

(3024263) Appearance of Synovial fluid

252

862

2.52

39.45

1.6

—

(3049717) Cytology report of Urine Cyto stain

1296

7534

1.50

39.09

2.5

2.8

—

(40768443) Skin Pathology biopsy report

1423

8437

1.47

38.90

1.2

—

(44813793)

293

1087

2.33

38.44

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

824

4382

1.63

36.80

2.3

2.2

g/l

129.4

130.0

0.30

650

3124

(3015235) Bicarbonate [Moles/volume] in Capillary blood

871

4712

1.60

36.28

2.9

3.0

mmol/l

25.0

24.7

0.98

779

4121

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1120

6418

1.52

36.17

2.5

2.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

846

4555

1.61

35.94

1.4

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

879

11571

0.64

35.82

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2642

17606

1.32

35.59

1.5

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

277

1042

2.29

35.24

1.1

mg/l

292.6

292.2

0.01

238

902

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1664

10338

1.40

35.22

8.0

10.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1293

7682

1.46

34.94

4.2

5.1

1.7

1.6

1.13

1226

7237

(3009542) Hematocrit [Volume Fraction] of Blood

21659

177422

1.20

34.60

19.6

14.7

39.4

39.7

4.62

14381

127578

(3024980) IgG subclass 4 [Mass/volume] in Serum

558

2720

1.77

34.37

1.5

1.6

g/l

0.7

0.8

2.15

398

2033

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

743

3919

1.64

34.29

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

743

3919

1.64

34.29

1.4

1.3

—

(3042631) Mycobacterium sp identified in Specimen

552

2688

1.78

34.13

2.6

2.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

282

1087

2.24

33.89

1.1

mg/l

41.0

47.0

0.99

229

891

(3011985) Renin [Units/volume] in Plasma

516

2472

1.80

33.70

1.4

mu/l

50.2

63.5

1.36

467

2186

(4062490)

383

1668

1.98

33.49

1.5

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2738

18490

1.30

33.33

2.1

2.3

g/l

0.2

4.10

2516

17218

(3003181) Sodium [Moles/volume] in Urine

626

3181

1.70

33.31

1.4

1.3

mmol/l

62.0

61.8

0.05

516

2497

(3037756) Immunofixation for Serum or Plasma

725

3845

1.63

32.76

1.4

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1256

7518

1.45

32.63

4.3

5.1

0.9

0.09

1190

7081

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1417

8673

1.42

32.62

1.6

1.7

g/l

1.6

1.06

1215

7385

(3009343) pH of Capillary blood

1795

11440

1.37

32.52

3.5

7.4

0.16

354

1526

(40757494) Bilirubin.total [Moles/volume] in Blood

243

898

2.33

32.26

2.1

umol/l

43.8

25.2

0.44

(4027681)

224

801

2.41

32.01

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

379

1674

1.95

31.85

1.5

1.4

g/l

0.4

2.98

246

1136

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

227

819

2.39

31.81

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

379

1676

1.95

31.74

1.5

1.4

g/l

2.7

3.0

3.25

243

1139

(3020779) Urea [Moles/volume] in Serum or Plasma

2599

17538

1.30

31.74

6.1

7.5

mmol/l

9.6

10.2

3.86

2467

16669

(3027135) IgG subclass 1 [Mass/volume] in Serum

379

1677

1.95

31.69

1.5

1.4

g/l

6.3

7.1

3.58

246

1137

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1731

11029

1.37

31.39

3.5

3.4

mmol/l

2.1

1.8

3.92

1261

8195

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1805

11595

1.36

31.07

3.6

3.5

kpa

5.2

5.1

3.79

1688

10681

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

136

382

3.06

30.92

1.7

1.8

mg/l

9.6

9.2

0.34

103

300

(3013166) Neutrophils/100 leukocytes in Synovial fluid

153

461

2.86

30.76

1.3

1.4

51.6

55.7

0.62

137

396

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

477

2299

1.79

30.58

1.3

pmol/l

264.9

286.4

0.52

383

1761

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

294

1205

2.10

30.37

1.3

u/ml

1.3

1.5

0.16

125

562

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

182

606

2.59

30.24

2.1

1.6

umol/l

142.2

120.9

0.31

296

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

544

2735

1.72

30.13

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

207

736

2.42

29.98

1.1

u/l

1.1

0.27

351

(3009214) Lutropin [Units/volume] in Serum or Plasma

696

3736

1.61

29.98

1.3

u/l

12.3

11.8

0.27

555

3034

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2115

13984

1.32

29.92

2.5

2.1

nmol/l

12.7

0.02

1839

12461

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

117

307

3.28

29.76

1.6

1.5

au/ml

144.1

99.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9033

69523

1.17

29.74

5.1

4.8

ug/l

2.9

3.3

0.44

8123

62354

(4094501)

956

5522

1.50

29.73

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

865

4906

1.53

29.32

1.8

2.1

mg/l

10.0

11.2

4.62

801

4566

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

491

2425

1.75

28.98

6.4

5.9

mg/l

11.9

11.6

0.73

459

2215

(3004451) EKG impression Narrative

236

903

2.25

28.95

1.4

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

609

3196

1.65

28.73

1.4

—

(3000012) Reticulocyte production index

263

1056

2.15

28.67

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2819

19457

1.27

28.64

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

493

2449

1.74

28.52

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

502

2516

1.72

28.15

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

250

992

2.17

28.09

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

322

1408

1.97

27.93

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

510

2575

1.71

27.85

1.4

—

(3045424) Erythrocytes [Presence] in Urine

579

3027

1.65

27.74

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

654

3528

1.60

27.63

2.1

1.8

pmol/l

199.0

201.4

0.23

603

3340

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

241

963

2.16

26.64

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

213

812

2.26

26.41

1.2

1.1

iu/ml

3.1

4.7

1.12

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

896

2.18

25.89

3.6

3.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

385

1834

1.81

25.74

3.6

3.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

237

958

2.13

25.47

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

889

5225

1.47

25.39

1.3

1.5

iu/ml

6.6

15.6

3.29

123

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

288

1262

1.97

24.89

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1262

1.96

24.56

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

288

1269

1.96

24.51

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

279

1218

1.97

24.38

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

203

786

2.22

24.30

1.5

ug/l

11.2

8.1

0.69

184

709

(40759836) Histone Ab [Presence] in Serum by Immunoblot

286

1261

1.95

24.30

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1268

1.95

24.24

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

262

1121

2.01

24.23

1.5

2.0

nmol/l

16.9

16.4

0.49

243

1048

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1269

1.95

24.18

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

756

4348

1.50

24.05

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

291

1300

1.93

23.80

1.4

1.3

mmol/l

2.0

2.2

2.52

270

1211

(3035637) Corticotropin [Mass/volume] in Plasma

431

2172

1.71

23.77

1.4

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

833

4899

1.47

23.74

1.9

1.7

nmol/l

41.5

42.3

0.49

805

4756

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

757

4368

1.50

23.71

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

327

1529

1.84

23.27

1.6

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

377

1853

1.75

22.75

1.7

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

344

1655

1.79

22.33

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

724

4200

1.49

22.12

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

156

563

2.38

22.02

2.2

1.9

ug/l

58.6

56.9

0.12

150

550

(3012565) Volume of 24 hour Urine

230

974

2.03

21.94

1.9

2.3

2044.6

1947.8

0.71

199

857

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

462

2432

1.64

21.65

1.1

au/ml

10.1

12.2

0.21

139

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

582

3243

1.55

21.48

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3580

26094

1.20

21.36

1.4

—

(3003694) ABO and Rh group [Type] in Blood

6598

50565

1.16

21.36

1.4

1.3

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

107

4.41

21.34

1.6

1.5

mg/l

1.8

1.7

0.23

(3016018) Differential panel - Cerebral spinal fluid

371

1856

1.72

21.07

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

533

2932

1.57

20.84

1.5

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

172

664

2.23

20.82

2.1

2.5

ug/l

20.7

287.5

1.05

163

630

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

807

4839

1.44

20.82

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

546

3024

1.56

20.72

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2399

24935

0.81

20.68

5.1

4.5

32.3

0.08

1703

16808

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7150

55221

1.15

20.62

4.6

4.1

21.9

0.08

3454

27066

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

747

4429

1.46

20.46

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

750

4451

1.46

20.45

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

368

1857

1.71

20.28

1.1

iu/ml

0.8

2.1

—

(3047181) Lactate [Moles/volume] in Blood

896

5508

1.41

20.15

5.0

6.2

mmol/l

1.2

1.3

3.73

784

4864

(3011288) Drugs identified in Urine by Screen method

448

2391

1.62

19.91

2.7

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

647

3752

1.49

19.84

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

245

1100

1.92

19.84

1.5

—

(3008295) Osmolality of Serum or Plasma

349

1749

1.72

19.74

1.4

mosm/kgh2o

277.5

278.9

0.53

264

1401

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

114

374

2.62

19.71

2.4

2.5

au/ml

181.7

159.1

0.16

(3023420) DNA double strand Ab [Units/volume] in Serum

354

1783

1.71

19.66

1.4

1.5

iu/ml

29.3

33.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

403

2107

1.65

19.46

5.3

7.3

mmol/l

7.3

7.5

0.75

348

1726

(3023410) Appearance of Cerebral spinal fluid

340

1699

1.72

19.44

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

304

2.80

19.42

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

439

2348

1.61

19.36

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

119

404

2.53

19.21

1.3

nmol/l

139.0

129.0

0.27

271

(3044927) Protein electrophoresis panel - Urine

339

1699

1.72

19.18

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

795

4836

1.42

19.00

2.5

2.4

ug/min

88.6

110.5

1.04

452

2885

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

407

2153

1.63

18.78

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

241

1097

1.89

18.76

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

243

1113

1.88

18.57

1.4

1.5

—

(3002256) Pathology report gross observation

3608

26638

1.19

18.44

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

679

4039

1.45

18.33

1.6

1.8

mu/l

292.3

315.4

0.82

616

3694

(3028707) Methadone [Presence] in Urine by Screen method

311

1542

1.74

18.31

2.1

2.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

203

885

1.97

17.97

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

142

540

2.26

17.90

1.2

g/l

0.3

0.90

109

428

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

329

1671

1.70

17.78

1.4

1.3

nmol/l

1.5

1.4

0.78

303

1495

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

263

1256

1.80

17.62

1.5

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

136

515

2.27

17.33

1.2

23.8

27.4

0.17

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

117

415

2.42

17.28

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

117

415

2.42

17.28

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

117

415

2.42

17.28

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

117

415

2.42

17.28

1.1

—

(3024928) Oxygen saturation in Venous blood

657

3932

1.44

17.20

2.6

3.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.55

17.06

1.0

—

(3039000) Anion gap in Blood

654

3922

1.44

16.94

5.5

7.3

mmol/l

10.8

11.3

4.10

596

3548

(3018572) Chloride [Moles/volume] in Blood

654

3923

1.44

16.92

5.5

7.3

mmol/l

105.2

0.00

596

3549

(3047007) Chlamydophila sp Ab [Presence] in Serum

424

2328

1.57

16.81

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

117

421

2.39

16.76

2.7

3.1

mg/l

7.4

8.2

0.53

338

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

270

1321

1.76

16.71

1.5

1.6

u/ml

20.8

26.1

0.75

281

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1658

11441

1.26

16.63

1.3

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

218

1004

1.87

16.44

1.1

iu/ml

9.1

8.5

0.13

264

(3017732) Neutrophils [#/volume] in Blood

1811

12642

1.24

16.40

2.6

3.0

e9/l

4.0

4.1

0.33

1411

9589

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

132

509

2.23

16.15

1.2

109.2

113.3

1.00

114

452

(3042111) Morphology [Interpretation] in Bone marrow Narrative

538

3137

1.48

16.15

1.5

1.6

—

(3016038) Potassium [Moles/volume] in Urine

244

1177

1.78

15.87

1.2

1.1

mmol/l

34.5

35.1

0.19

205

1013

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

517

3002

1.49

15.85

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

135

532

2.18

15.69

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

302

1554

1.67

15.61

1.7

2.0

g/24h

1.1

1.0

0.10

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

218

1022

1.84

15.58

1.8

1.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1159

0.29

15.28

11.1

11.4

nmol/l

889.1

1712.8

0.47

1115

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

174

764

1.96

15.18

1.2

1.3

63.3

54.5

0.50

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

9.03

15.18

2.0

1.6

nmol/l

181.1

204.1

0.09

(3004616) Nuclear Ab [Presence] in Serum

382

2102

1.57

15.06

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

161

690

2.01

15.05

1.4

1.6

nmol/l

4.5

7.4

0.36

135

591

(3007566) Smooth muscle Ab [Titer] in Serum

805

5117

1.36

14.87

1.2

titre

142.9

124.2

0.19

440

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

174

775

1.93

14.59

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

247

2.71

14.57

1.4

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1217

0.32

14.47

14.8

16.1

nmol/l

1558.7

3508.6

0.71

1164

(3036489) Thrombin time

1052

6988

1.30

14.35

1.9

2.0

21.2

21.7

1.55

917

6164

(3034770) Mitochondria Ab [Titer] in Serum

794

5070

1.35

14.26

1.2

titre

1083.3

899.8

0.32

166

(3016750) Collection duration of Urine

244

1222

1.72

14.00

2.3

2.2

min

497.4

499.8

0.14

176

904

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.15

13.97

1.1

1.0

u/ml

0.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

253

1284

1.70

13.84

1.6

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

630

3895

1.40

13.84

1.8

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

118

465

2.18

13.78

1.6

ug/l

9.8

9.0

0.96

118

465

(3023183) Ammonium ion [Moles/volume] in Plasma

646

4031

1.38

13.44

2.1

2.7

umol/l

33.0

34.6

0.81

527

3441

(3017569) Oxygen content in Arterial blood

185

879

1.81

12.77

2.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

680

4318

1.36

12.71

1.8

iu/l

28.9

8.7

0.59

248

1547

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.59

12.70

1.1

1.0

u/ml

0.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.67

12.60

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

139

604

1.98

12.59

1.3

1.2

g/l

1.2

0.6

—

(3002619) Bacteria identified in Specimen by Culture

335

2.33

12.52

1.4

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

121

501

2.08

12.51

1.7

2.3

ug/l

1.0

1.1

0.01

112

477

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

332

2.33

12.33

1.3

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

147

658

1.92

12.23

1.1

ng/l

530.5

524.9

0.01

173

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

129

552

2.01

12.21

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

154

701

1.89

12.19

2.9

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

141

3.11

12.18

2.1

1.7

umol/l

52.9

46.9

0.49

141

(3033923) Metanephrine [Moles/time] in 24 hour Urine

319

2.34

12.10

1.1

umol/24h

0.6

0.7

0.97

161

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

362

2.25

12.09

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

361

2066

1.50

12.01

3.6

3.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

254

2.50

11.87

1.5

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

301

1664

1.56

11.76

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

223

1146

1.67

11.73

1.3

1.2

titre

473.8

409.6

0.07

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

678

4362

1.34

11.67

1.1

u/ml

3.8

7.4

2.05

557

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

663

4252

1.35

11.66

2.8

3.5

u/ml

361.1

850.4

1.78

599

3862

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

761

4985

1.32

11.57

1.9

1.7

—

(3020650) Glucose [Presence] in Urine

113

474

2.05

11.33

1.5

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

118

503

2.02

11.33

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

216

1114

1.67

11.23

1.3

titre

64.2

73.9

0.16

(3036670) Protein [Mass/volume] in Synovial fluid

119

511

2.00

11.20

1.3

1.2

g/l

40.4

39.4

0.35

272

(3007916) DNA double strand Ab [Titer] in Serum

206

2.63

11.17

1.2

1.3

—

173.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

269

2.39

10.99

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

225

2.52

10.78

2.0

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

241

1292

1.60

10.78

3.2

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

463

2841

1.40

10.74

1.6

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

337

2.22

10.71

1.3

1.2

mg/l

0.9

36.4

0.99

250

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.63

10.68

1.1

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

363

2135

1.46

10.61

1.2

u/l

59.9

62.6

0.34

261

1409

(3039443) Prostate specific Ag panel - Serum or Plasma

334

4168

0.68

10.59

1.5

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

221

1170

1.62

10.42

1.2

u/l

86.9

92.3

0.35

189

1020

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

216

1138

1.63

10.38

1.2

u/l

31.2

23.5

1.08

180

975

(3034274) Bile acid [Moles/volume] in Serum --fasting

183

924

1.70

10.35

1.5

1.7

umol/l

6.5

11.8

2.90

123

677

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

111

480

1.99

10.29

1.1

97.2

82.4

3.56

235

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

419

2549

1.42

10.24

1.9

2.0

u/l

2135.3

3589.1

0.91

130

919

(3020717) Zinc [Moles/volume] in Serum or Plasma

153

737

1.78

10.20

1.4

umol/l

23.3

27.6

0.97

143

701

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

266

1482

1.54

10.12

1.7

1.8

mg/l

3.9

3.8

0.08

256

1407

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

500

3146

1.37

10.01

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

418

2553

1.41

10.00

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

121

545

1.91

9.99

1.6

1.2

umol/l

2.8

3.5

2.10

107

499

(3038177) Helicobacter pylori Ab [Presence] in Serum

465

2905

1.38

9.75

1.3

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

144

2.80

9.48

1.5

1.2

pmol/l

9.0

15.9

1.85

123

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

150

736

1.75

9.44

1.7

1.8

157.8

152.5

0.30

142

693

(3045716) Anion gap in Serum or Plasma

159

794

1.72

9.40

2.1

2.2

mmol/l

9.0

9.3

0.40

129

598

(3004775) Volume in Urine collected for unspecified duration

293

1695

1.49

9.38

2.5

2.3

662.3

690.5

0.60

204

1145

(3010838) Calcium [Moles/time] in 24 hour Urine

180

933

1.66

9.28

1.7

1.6

mmol/24h

6.7

5.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

242

1348

1.54

9.26

1.5

1.4

promille

1.6

1.3

2.42

163

1064

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

110

494

1.91

9.20

1.1

95.1

84.1

3.21

244

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

809

5516

1.27

9.12

2.2

2.4

g/l

3.7

3.6

0.11

768

5276

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2879

21983

1.14

9.07

3.2

4.4

ug/l

26.8

27.0

0.01

2353

17845

(3009015) Lactate [Moles/volume] in Synovial fluid

163

2.63

9.00

1.3

1.2

mmol/l

5.1

7.0

1.65

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

245

1383

1.52

8.85

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

459

1.93

8.83

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

363

2214

1.41

8.82

1.4

1.3

u/l

34.4

35.8

0.32

282

1798

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

120

563

1.83

8.80

1.4

pmol/l

15.5

15.4

0.07

483

(3029075) Extractable nuclear Ab panel - Serum

112

515

1.87

8.75

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

672

4503

1.29

8.74

3.5

3.0

mmol/l

1.6

0.70

652

4417

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

697

4694

1.28

8.71

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

759

5166

1.27

8.70

2.7

3.0

mg/l

1.6

0.07

672

4726

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

914

1.64

8.56

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

909

1.64

8.51

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

164

851

1.66

8.47

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

141

703

1.72

8.44

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

164

2.56

8.40

1.3

1.2

nmol/l

0.2

0.3

0.55

110

(1001926) Buprenorphine [Presence] in Urine by Screen method

453

2891

1.35

8.37

1.9

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

222

1243

1.54

8.35

1.8

1.9

—

(3000034) Microalbumin [Mass/volume] in Urine

290

1724

1.45

8.15

2.9

3.0

mg/l

31.1

49.2

0.91

201

1237

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

225

1271

1.52

8.14

1.6

1.5

u/l

7.6

6.0

0.64

116

594

(3023323) Follitropin [Units/volume] in Serum or Plasma

1026

7281

1.22

8.06

1.4

1.3

iu/l

32.5

35.7

2.23

892

6332

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

160

841

1.63

7.90

1.2

1.3

mmol/l

6.1

6.0

0.64

145

788

(3030313) Adrenal Ab [Titer] in Serum

3.32

7.81

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

107

2.89

7.73

1.2

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

483

3152

1.32

7.71

3.0

3.4

1.2

1.5

1.26

365

2461

(3016244) Insulin [Units/volume] in Serum or Plasma

155

814

1.64

7.69

2.5

3.3

mu/l

26.2

26.4

0.03

149

761

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

106

501

1.82

7.65

1.2

1.1

116.0

103.4

3.14

464

(1002224) Polysomnography panel

1109

7971

1.20

7.64

1.1

—

(44806118)

311

1897

1.41

7.62

1.5

—

(44790047)

311

1898

1.41

7.60

1.5

—

(44790048)

311

1898

1.41

7.60

1.5

—

(44790049)

311

1898

1.41

7.60

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

143

739

1.66

7.56

1.1

u/ml

76.0

8.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

110

528

1.79

7.56

1.3

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

104

2.89

7.53

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

792

5514

1.24

7.51

1.8

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

114

2.79

7.46

1.3

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

955

6786

1.21

7.43

2.9

u/ml

0.3

0.19

541

3846

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

261

1552

1.45

7.38

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

261

1552

1.45

7.38

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

261

1552

1.45

7.38

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.95

7.37

1.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

452

1.84

7.35

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

386

1.91

7.31

2.1

2.5

mmol/l

6.8

7.6

1.60

229

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

357

2249

1.37

7.24

2.3

2.0

mg/l

30.6

27.2

0.43

619

(3001019) Free T4 and TSH panel - Serum or Plasma

929

9550

0.83

7.12

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

251

2.12

7.00

1.6

ug/l

91.0

110.5

0.84

204

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

154

2.45

6.95

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

303

1874

1.39

6.90

1.7

—

(3019977) pH of Arterial blood

185

1042

1.53

6.87

2.5

2.4

7.4

0.01

389

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

171

947

1.55

6.85

2.0

2.7

u/ml

803.7

1291.9

2.88

171

933

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

335

1.95

6.84

1.1

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

222

1301

1.47

6.81

1.8

1.5

umol/l

70.9

71.6

0.05

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

231

1366

1.45

6.77

1.2

u/ml

124.3

69.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

295

1827

1.39

6.68

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

216

1265

1.47

6.66

1.0

ng/l

292.3

367.3

1.37

130

938

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

217

1274

1.46

6.61

1.0

ng/l

799.8

721.0

1.52

128

908

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

109

545

1.72

6.57

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1302

0.57

6.57

1.3

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.80

6.56

1.4

1.6

umol/l

1.0

0.7

1.46

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

217

1276

1.46

6.56

1.0

ng/l

36.2

43.7

2.26

130

937

(3042517) Benzodiazepines panel - Urine

2.96

6.55

2.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

169

944

1.54

6.54

1.8

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

163

904

1.55

6.52

2.1

ug/min

90.8

112.6

0.16

216

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

230

1370

1.44

6.50

1.2

u/ml

60.8

45.0

0.37

104

(3038026) Centromere Ab [Units/volume] in Serum

235

1406

1.44

6.49

1.3

1.2

u/ml

105.8

47.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

310

1949

1.37

6.43

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

220

1304

1.45

6.39

1.2

u/ml

3.9

7.3

0.57

(3043238) Trisomy 21 risk [Likelihood] in Fetus

977

0.51

6.36

1.5

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

123

642

1.65

6.34

1.5

1.6

umol/l

2.2

2.0

1.94

114

598

(4024509)

273

1685

1.39

6.34

1.6

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1098

0.54

6.30

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

382

1.84

6.29

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

126

664

1.63

6.26

1.4

1.5

umol/l

30.3

29.8

0.23

117

633

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1094

0.54

6.23

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

346

2225

1.34

6.21

1.3

1.2

mmol/l

7.3

7.5

0.66

270

1617

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

279

1735

1.38

6.21

2.9

2.8

—

(3038515) Glucose [Moles/volume] in Venous blood

618

4283

1.24

6.19

3.7

3.1

mmol/l

7.4

7.7

0.90

596

4215

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1100

0.54

6.14

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1099

0.55

6.12

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

459

3078

1.28

6.09

1.4

1.3

u/l

39.0

33.8

0.25

409

2655

(3002621) Streptococcal DNAse B [Units/volume] in Serum

133

2.45

6.05

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

435

2904

1.29

5.98

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

401

1.80

5.98

1.4

1.2

36.6

39.5

0.27

279

(3012494) Peanut IgE Ab [Units/volume] in Serum

353

1.85

5.91

1.0

1.1

u/ml

0.7

0.9

0.22

166

(3044242) Glucose [Moles/volume] in Arterial blood

161

912

1.52

5.90

2.2

2.0

—

(3017704) Immunofixation for Urine

165

944

1.50

5.78

1.4

1.6

—

(3016879) Cocaine [Presence] in Urine

528

3627

1.25

5.76

1.9

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

338

2194

1.32

5.73

1.1

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1164

0.57

5.72

1.5

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

221

1345

1.41

5.62

1.9

73.6

72.0

0.90

211

1295

(3047352) Trisomy 18 risk [Likelihood] in Fetus

936

0.53

5.60

1.5

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

169

980

1.48

5.56

1.1

ratio

1.0

1.1

1.23

369

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

348

2280

1.31

5.54

2.6

3.5

nmol/l

4.0

8.3

1.09

337

2225

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

168

974

1.48

5.53

1.3

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

172

1002

1.47

5.53

1.6

2.1

103.5

96.1

1.75

159

956

(3005033) Fetal Nuchal fold Thickness US

932

0.53

5.53

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

139

2.35

5.53

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

190

1131

1.44

5.47

1.3

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

350

1.82

5.46

2.3

3.3

ml/dl

15.0

14.6

0.57

329

(3006270) Folate [Moles/volume] in Blood

256

1608

1.37

5.42

1.2

nmol/l

335.8

367.9

1.67

209

1322

(1761482) Bacteria [#/volume] in Urine by Culture

742

5317

1.20

5.41

5.1

3.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

390

2604

1.29

5.40

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

630

1.59

5.39

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

303

1.87

5.36

2.3

ug/l

2.9

3.8

1.49

101

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1036

7647

1.17

5.35

2.7

3.7

u/ml

352.6

2074.7

1.43

848

6581

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

384

1.77

5.34

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

416

1.73

5.33

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

121

659

1.58

5.33

1.1

miu/ml

1488.9

1545.9

0.22

121

659

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

398

2671

1.28

5.31

1.2

u/ml

3.5

3.9

0.17

135

953

(3028717) Thiamine [Mass/volume] in Blood

170

2.17

5.25

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

624

4413

1.22

5.23

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

229

1423

1.38

5.20

1.8

1.7

—

(3011412) CD3 cells [#/volume] in Blood

268

1711

1.35

5.14

2.2

2.3

e9/l

1.2

1.1

0.96

178

1042

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

215

1325

1.39

5.13

1.9

15.3

14.8

0.17

534

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

737

5307

1.20

5.12

2.4

2.3

190.5

196.2

0.95

689

5032

(3033705) Calcium.ionized [Moles/volume] in Venous blood

375

2511

1.28

5.11

2.5

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

410

1.72

5.05

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1328

10026

1.14

5.05

2.7

3.8

u/ml

37.8

58.6

3.54

1280

9690

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

183

1100

1.43

5.04

1.7

1.8

u/field

2.4

2.6

0.16

137

791

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

162

2.17

5.03

1.1

umol/24h

1.6

1.8

1.05

162

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

240

1512

1.36

5.02

1.1

1.2

titre

81.9

177.0

4.25

263

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

383

2580

1.28

4.99

1.1

g/l

1.5

0.14

345

2348

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

269

1.88

4.92

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1066

7949

1.16

4.85

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.57

4.80

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

554

3908

1.22

4.80

1.9

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

495

1.63

4.79

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

796

5809

1.18

4.77

2.0

2.1

92.7

90.4

2.11

742

5405

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

958

7096

1.16

4.77

4.1

3.8

mmol/l

25.0

24.9

0.87

896

6536

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

134

767

1.50

4.76

2.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

152

893

1.46

4.75

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

261

1686

1.33

4.67

2.0

u/field

2.6

2.3

0.27

113

693

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1032

0.60

4.61

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

556

3943

1.21

4.59

1.9

1.7

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.75

4.56

2.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

557

3955

1.21

4.54

1.9

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

425

2936

1.24

4.52

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

268

1748

1.32

4.50

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

137

798

1.47

4.50

3.4

5.4

mg/l

68.3

2289.7

2.56

100

569

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

156

933

1.44

4.47

2.9

3.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

338

2276

1.28

4.47

1.1

u/ml

1.6

3.2

5.01

108

1088

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

342

1.73

4.44

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

381

1.69

4.42

1.2

1.3

mu/l

65.0

70.9

0.10

287

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

520

1.58

4.40

1.8

2.0

u/l

19.1

40.0

2.56

466

(3047189) Immunofixation for 24 hour Urine

141

834

1.45

4.30

1.5

1.8

—

(3022313) Gas panel - Capillary blood

1101

8308

1.14

4.27

3.9

3.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

444

1.62

4.27

1.2

pmol/l

248.7

299.3

0.84

331

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

302

1.76

4.25

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

650

6563

0.85

4.22

1.8

1.7

mg/l

4.0

3.5

0.51

487

4679

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

107

2.33

4.22

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

209

1329

1.35

4.20

2.0

1.9

mmol/l

7.2

7.1

0.27

169

881

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

400

1.65

4.19

1.6

1.5

ug/l

0.5

0.4

0.63

250

(3037121) Protein [Mass/volume] in Urine

866

6437

1.16

4.17

2.8

3.3

g/l

0.3

0.21

334

2895

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

108

2.30

4.13

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

294

1969

1.28

4.10

1.3

1.4

nmol/l

0.3

0.10

204

1431

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

391

2711

1.24

4.07

1.1

u/ml

1.1

1.5

0.42

133

975

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

253

1663

1.31

4.07

4.3

5.2

u/ml

181.3

85.2

0.88

510

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

196

1.93

4.00

1.0

1.1

—

(4306422)

373

2580

1.24

3.98

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

179

2069

0.74

3.89

1.4

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

688

5060

1.17

3.84

1.3

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

230

1.83

3.83

1.7

1.3

48.4

52.0

0.18

109

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

937

7055

1.14

3.80

1.9

1.7

—

(4198724)

459

1.57

3.77

1.9

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

314

1.69

3.75

1.1

1.4

titre

217.6

234.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

407

1.60

3.72

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

142

2.05

3.71

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

537

3883

1.19

3.69

1.9

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

137

2.07

3.66

1.0

1.1

—

(3001729) Color of Synovial fluid

143

2.04

3.65

1.2

1.7

—

(3027874) Urate [Moles/volume] in Urine

2.80

3.60

1.1

mmol/l

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

153

952

1.38

3.59

1.4

1.5

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.63

3.58

1.1

1.0

u/ml

0.6

0.04

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

153

953

1.38

3.57

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

152

946

1.38

3.57

2.9

2.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.38

3.55

1.1

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.28

3.53

1.2

1.1

—

3.4

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

122

2.11

3.52

1.2

1.1

u/field

1.1

1.2

0.47

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

108

636

1.46

3.46

1.8

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

369

2593

1.22

3.45

1.2

u/ml

4.8

3.7

0.65

156

1182

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

159

1.94

3.41

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

360

2528

1.22

3.40

1.1

125.2

117.0

5.07

319

2280

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

550

4022

1.18

3.35

1.6

1.7

nmol/l

0.9

0.8

0.62

479

3347

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

385

1.58

3.34

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

345

1.62

3.34

1.3

1.2

103.1

86.2

2.01

119

(3027456) Digoxin [Moles/volume] in Serum or Plasma

520

3787

1.18

3.33

3.0

3.1

nmol/l

0.8

0.08

401

2951

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

211

1396

1.30

3.32

1.2

mmol/l

12.1

0.05

438

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

413

1.56

3.31

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.57

3.27

1.0

1.1

mmol/l

4.9

5.5

0.46

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

103

2.17

3.27

1.1

nmol/l

10.3

14.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

175

1133

1.33

3.23

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1011

7749

1.12

3.16

2.1

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

530

1.47

3.12

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

345

2437

1.22

3.11

1.1

u/ml

3.1

3.7

0.31

162

1107

(3035611) Eosinophils/100 leukocytes in Synovial fluid

117

2.05

3.10

1.3

1.8

0.6

0.8

0.39

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

525

3853

1.17

3.09

4.9

5.9

iu/ml

473.6

1218.6

1.16

627

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

135

1.97

3.08

1.2

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

581

1.45

3.08

1.7

1.9

8.3

10.8

2.04

533

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

425

3070

1.19

3.03

1.2

1.3

u/ml

292.1

282.8

0.27

247

2001

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

160

1.88

3.03

1.3

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

402

1.54

3.02

1.7

1.8

e6/l

139.1

1702.5

1.41

203

(3015183) Erythrocyte sedimentation rate

131

822

1.37

2.99

1.2

—

(3036180) Methadone [Presence] in Urine

6.00

2.99

1.1

3.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

349

1.57

2.98

1.2

74.3

77.9

0.19

116

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

102

2.10

2.95

2.0

1.4

8.9

13.9

1.07

(4211845)

147

942

1.34

2.94

3.5

3.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

450

3277

1.18

2.94

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

337

1.58

2.93

2.8

2.5

mg/l

40.6

66.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.12

2.91

1.1

u/l

48.4

50.8

0.08

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.19

2.89

8.0

8.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

286

2001

1.23

2.87

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

133

1.94

2.86

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.33

2.85

1.1

u/l

223.9

584.5

1.12

(3016228) CD19 cells/100 cells in Blood

124

779

1.37

2.83

2.0

8.2

8.9

0.25

119

762

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4972

40830

1.05

2.78

3.1

3.0

ug/l

0.7

0.8

10.56

3447

26885

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.20

2.77

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

153

997

1.32

2.76

1.6

1.4

nmol/l

1.2

1.3

0.55

123

780

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1090

0.71

2.75

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1679

13304

1.09

2.75

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

763

5807

1.13

2.74

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.23

2.73

1.6

1.5

u/l

0.6

0.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

151

1687

0.77

2.71

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

111

691

1.38

2.70

3.1

2.9

umol/l

28.4

29.1

0.32

526

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

118

1.96

2.69

1.8

1.4

45.1

42.1

0.13

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

393

1.51

2.69

1.9

1.5

—

(3010503) CD19 cells [#/volume] in Blood

173

1153

1.29

2.66

2.5

2.6

e9/l

0.3

0.4

0.34

167

1123

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

173

1153

1.29

2.66

2.4

2.5

e6/l

494.1

548.8

0.55

146

972

(3028433) Virus identified in Specimen by Culture

593

1.40

2.63

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

472

4686

0.86

2.63

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

380

2758

1.18

2.62

2.0

2.6

u/ml

117.4

1164.1

1.77

373

2703

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

354

3595

0.84

2.62

3.5

u/ml

37.9

38.8

0.04

346

3453

(4015189)

494

1.44

2.61

2.4

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

438

1.47

2.60

1.2

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

308

1.56

2.57

5.6

5.1

ug/min

36.0

49.2

1.47

256

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.95

2.56

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

120

764

1.35

2.56

2.0

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

547

1.41

2.54

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

127

1.89

2.53

1.0

1.1

u/l

8.1

10.5

0.47

127

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.37

2.50

1.0

u/ml

0.1

0.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

244

1.62

2.46

1.2

1.3

nmol/l

6.4

222118.5

1.26

199

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

191

1304

1.26

2.45

1.4

umol/l

13.5

12.8

0.78

181

1233

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.07

2.43

1.7

1.3

1.9

1.2

0.27

(3051593) INR in Capillary blood by Coagulation assay

143

943

1.30

2.41

9.9

10.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.99

2.41

1.6

1.5

mg/l

2.1

1.8

0.10

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

193

1.69

2.40

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

133

870

1.31

2.39

3.5

3.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.29

2.38

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

149

1.78

2.36

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

112

716

1.34

2.36

1.0

1.1

102.8

98.4

0.88

568

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.36

2.36

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

323

1.51

2.32

1.1

—

(3036603) Volume of Urine

198

1368

1.24

2.31

1.6

1873.7

1950.0

0.26

335

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.34

2.30

1.4

nmol/l

404.3

482.0

0.37

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.61

2.30

1.3

1.0

—

(3022689) Creatine [Moles/volume] in Urine

551

1.39

2.29

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

191

1316

1.25

2.29

2.6

2.5

e6/l

714.7

701.7

0.04

529

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

163

1104

1.27

2.26

2.5

2.6

e9/l

0.2

0.38

144

963

(3001186) Copper [Moles/volume] in Serum or Plasma

389

1.46

2.24

1.3

1.2

umol/l

17.0

17.3

0.14

344

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

666

0.67

2.22

2.3

2.6

nmol/l

123.0

155.1

1.49

593

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

119

1329

0.77

2.20

1.4

1.3

g/l

1.6

1.5

0.42

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

943

0.73

2.16

1.4

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.26

2.15

1.1

1.0

u/ml

0.1

0.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

240

1.57

2.14

1.3

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

3.75

2.14

1.7

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

398

0.58

2.13

1.4

1.2

—

(4281824)

233

2401

0.83

2.11

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

123

1.81

2.11

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.31

2.11

1.0

u/ml

0.4

0.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

686

1.33

2.10

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

139

934

1.28

2.09

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

360

1.45

2.08

1.7

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

265

1913

1.19

2.04

1.1

99.1

96.6

0.84

246

1784

(3008401) Mugwort IgE Ab [Units/volume] in Serum

320

2348

1.17

2.03

1.1

u/ml

1.0

1.1

0.11

127

893

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.99

2.01

1.1

u/field

1.2

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

258

1.53

2.01

1.9

2.1

umol/l

15.0

18.9

1.79

258

(3013727) Leukocytes other/100 leukocytes in Blood

640

1.33

1.99

3.2

3.6

53.0

53.3

0.05

621

(21494434) Karyotype in Bone marrow

236

1691

1.20

1.98

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

120

1.79

1.96

1.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

4.76

1.96

1.0

—

(36303858) Crystals [Presence] in Urine

2.98

1.91

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

1.90

0.0

3.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

128

1.74

1.88

2.3

2.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

104

1.81

1.82

1.3

umol/24h

435.8

313.3

1.15

104

(3041672) Baker's yeast Ab [Presence] in Serum

2.14

1.81

1.0

—

(4133840)

517

1.34

1.80

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.97

1.78

1.1

u/ml

0.0

0.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

112

750

1.28

1.78

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

170

1.61

1.78

1.3

1.2

ug/l

60.8

117.4

1.99

108

(3032057) Clostridioides difficile [Presence] in Stool

359

1.41

1.76

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

144

996

1.24

1.75

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

193

1376

1.20

1.75

1.1

mg/l

284.3

507.3

0.52

171

1237

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.74

1.75

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

152

1059

1.23

1.73

2.9

2.8

39.5

38.2

0.24

339

(3017354) Segmented neutrophils/100 leukocytes in Blood

260

1906

1.17

1.72

3.3

3.4

61.6

58.5

1.26

152

1229

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

145

1.66

1.72

2.6

1.9

—

(4212803)

165

1.61

1.72

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

465

3552

1.12

1.71

1.3

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

172

1.60

1.71

1.3

1.2

u/ml

0.2

3.5

1.03

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

507

0.68

1.70

1.4

33.1

21.5

1.37

423

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

262

1.47

1.69

1.1

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.90

1.69

1.2

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.90

1.69

1.2

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

131

901

1.25

1.69

1.1

1.0

u/ml

0.4

1.7

1.74

224

(3024932) HLA-DR beta [Type]

686

0.72

1.67

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

108

730

1.27

1.62

2.0

2.4

umol/l

54.2

54.6

0.05

596

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

526

4063

1.11

1.61

1.3

miu/ml

215.4

223.3

0.18

209

1732

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.93

1.61

12.7

12.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

423

3229

1.13

1.60

1.3

1.5

u/ml

115.9

114.8

0.07

109

722

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

323

1.41

1.59

1.1

pmol/l

4.5

9.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

118

810

1.25

1.57

2.3

2.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

620

1.29

1.57

1.4

3.4

2.5

0.43

515

(3002079) Sodium [Moles/time] in 24 hour Urine

3.03

1.56

1.0

1.1

mmol/24h

144.9

157.6

—

(3007463) Buprenorphine [Presence] in Urine

3.03

1.56

5.2

8.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

150

1.60

1.54

1.0

1.1

—

(4035726)

2144

19283

0.95

1.53

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.82

1.53

1.1

1.2

ng/l

2686.9

4845.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

315

2370

1.14

1.51

1.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

2.9

2.2

0.17

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

2.8

2.4

0.10

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

0.4

1.4

1.58

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

2.4

3.3

0.40

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

1.9

2.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

1.2

2.0

0.85

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

2.8

1.7

0.25

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.75

1.51

1.6

1.5

mg/l

0.7

1.1

0.25

(3051651) Icteric interference index of Serum or Plasma

170

1218

1.20

1.51

4.1

4.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

200

1454

1.18

1.51

1.5

1.4

u/l

12.9

12.8

0.04

189

1407

(21494815) CD4 cells/100 lymphocytes in Specimen

224

1644

1.17

1.51

2.1

41.7

38.9

0.29

198

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.97

1.49

1.0

u/ml

0.2

0.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

322

2430

1.14

1.48

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

310

2334

1.14

1.48

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

214

1.48

1.47

1.5

1.7

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.26

1.47

1.1

—

0.1

—

(4146454)

226

2246

0.86

1.44

2.5

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

309

2333

1.14

1.43

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

170

1226

1.19

1.42

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

237

1.45

1.42

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

309

2334

1.14

1.42

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

381

2916

1.12

1.42

1.1

iu/ml

381.5

1198.0

0.65

561

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

111

768

1.24

1.41

1.1

u/ml

5.2

6.3

0.23

128

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

420

1.33

1.40

3.8

6.2

72.1

70.3

0.26

343

(3024522) Salmonella sp identified in Specimen by Organism specific culture

314

2378

1.13

1.39

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

303

1.39

2.2

3.2

—

(40757373) Influenza virus identified in Isolate

362

1.35

1.38

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

169

1223

1.19

1.37

5.8

6.5

—

(3024471) HLA-A [Type]

710

0.76

1.37

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

355

1.35

1.37

2.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

257

0.60

1.36

1.4

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

455

3528

1.11

1.35

1.3

1.4

u/ml

14.6

20.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

327

1.36

1.34

1.3

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

551

1.28

1.34

1.4

26.0

20.1

0.95

489

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

1.33

0.0

1.0

—

0.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.57

1.32

1.3

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

256

1.41

1.31

1.0

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

206

1.46

1.31

1.1

u/ml

0.0

0.4

1.74

129

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.37

1.29

1.0

—

64.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.37

1.29

1.1

1.0

2.0

2.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

221

0.58

1.29

12.0

9.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

615

0.75

1.29

1.3

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.85

1.27

1.0

1.1

pmol/l

169.7

229.4

—

(40758358) Immune stain study

102

0.42

1.25

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

137

0.50

1.25

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

273

1.38

1.25

1.9

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

138

0.50

1.25

1.0

—

(4268621)

232

1738

1.15

1.24

2.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

512

1.27

1.24

1.6

1.9

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

288

1.37

1.24

1.4

1.8

pmol/l

43.1

67.0

0.62

239

(3018001) Oat IgE Ab [Units/volume] in Serum

1.66

1.24

1.1

1.0

u/ml

0.1

0.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

257

1943

1.14

1.21

1.3

—

(3025130) Human papilloma virus identified in Specimen

282

2145

1.13

1.21

1.6

1.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.14

1.19

1.1

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.34

1.18

1.2

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

319

0.67

1.18

4.2

5.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

433

1.29

1.17

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

388

1.30

1.17

1.8

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

203

1516

1.15

1.16

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

699

0.78

1.14

4.4

5.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.52

1.14

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

185

1.44

1.11

2.2

2.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.80

1.11

1.0

1.1

umol/24h

0.4

0.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

129

1.53

1.10

6.4

4.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

157

0.55

1.10

4.9

7.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

249

1896

1.13

1.08

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

237

1.38

1.08

1.9

2.7

u/field

0.6

0.01

237

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.89

1.08

1.1

1.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

124

1.52

1.04

2.7

3.2

pmol/l

156.9

69.0

—

(3022475) Manganese [Moles/volume] in Blood

127

0.54

1.04

1.1

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.98

1.04

1.0

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.67

1.02

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

435

1.26

1.02

2.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

196

1.40

1.02

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

126

1.50

0.98

1.2

mg/l

43.0

47.6

0.53

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

102

734

1.19

0.97

1.4

55.6

62.6

1.12

597

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

250

1.34

0.96

1.3

1.5

—

(3047185) IgG [Mass/volume] in Urine

1.86

0.96

1.0

1.1

—

42.6

—

(3018291) Platelet Ab [Presence] in Serum

1.94

0.96

1.0

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.74

0.95

1.2

1.7

ug/l

196.6

107.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

286

2217

1.11

0.94

1.1

u/ml

2.5

1.6

0.32

480

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

147

1095

1.15

0.93

1.2

1.1

u/l

28.5

26.1

0.09

105

840

(3019225) pH of Specimen

2307

19135

1.04

0.93

4.3

4.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

237

1.34

0.92

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

252

1.33

0.92

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

334

2614

1.10

0.92

1.9

ug/l

28.7

23.6

0.45

326

2561

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

157

1.42

0.91

1.1

iu/ml

6.6

16.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

747

1.18

0.91

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

201

1532

1.13

0.91

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

378

2981

1.09

0.89

2.5

2.7

u/ml

2270.2

3360.3

0.19

175

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

421

1.24

0.89

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

110

0.55

0.89

3.1

3.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

196

1.36

0.85

2.2

2.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

517

1.21

0.85

1.5

iu/ml

—

66000216.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

146

1097

1.14

0.84

1.2

1.1

u/l

84.2

87.9

0.14

112

873

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.57

0.83

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

808

0.84

0.83

1.6

ug/l

4.0

5.2

0.19

554

(3012989) Citrate [Moles/time] in 24 hour Urine

1.91

0.82

2.7

1.4

mmol/24h

2.2

2.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.91

0.82

1.0

1.1

titre

770.0

2179.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

198

1.34

0.81

1.1

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

118

1.45

0.80

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

474

4353

0.93

0.80

4.2

3.1

mg/l

23.7

27.8

1.72

311

2805

(44806071)

222

1.31

0.78

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

155

1177

1.13

0.78

1.3

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

562

1.19

0.77

2.6

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

562

1.19

0.77

2.6

2.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

117

872

1.15

0.77

29.0

28.2

ug/l

112.2

114.1

0.13

102

728

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.56

0.77

1.3

1.2

1.4

0.76

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

528

4249

1.07

0.76

1.5

1.4

pmol/l

152.4

155.3

0.03

514

4151

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.72

0.76

1.2

—

(3041184) Isoniazid [Presence] in Urine

2.14

0.75

2.4

2.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

175

1675

0.90

0.75

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

131

987

1.14

0.75

2.0

1.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

239

1.29

0.74

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

194

1.33

0.74

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

114

0.60

0.74

1.1

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.54

0.73

1.1

1.0

u/ml

0.2

2.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

131

989

1.14

0.73

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

131

989

1.14

0.73

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

131

989

1.14

0.73

2.0

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.68

0.72

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.61

0.72

1.0

u/l

855.1

275.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.61

0.72

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

583

1.18

0.72

1.5

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

245

1920

1.09

0.71

1.3

mmol/l

6.4

6.3

0.12

229

1774

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.95

0.71

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

181

1721

0.90

0.71

2.3

2.4

—

(3026726) Creatinine [Moles/volume] in Specimen

177

0.68

0.71

2.1

2.5

umol/l

393.0

397.6

0.01

170

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.72

0.70

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

247

1941

1.09

0.68

1.1

1.0

u/ml

5.0

3.2

0.64

693

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.86

0.68

1.0

3.1

mu/l

0.7

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

158

1214

1.12

0.68

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.67

0.68

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

153

1464

0.90

0.68

1.5

1.3

pmol/l

92.8

75.1

0.74

456

(3005570) Glucose [Moles/volume] in Urine

243

1910

1.09

0.67

1.9

1.8

—

9.0

—

(3001556) Androgen free Index in Serum or Plasma

1.60

0.67

1.7

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

158

1219

1.11

0.64

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

156

1204

1.11

0.64

1.3

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

425

1.19

0.63

1.1

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

893

0.87

0.62

33.1

34.3

ug/l

7.1

7.3

0.46

803

(3023430) Cat dander IgE Ab [Units/volume] in Serum

232

1830

1.09

0.61

1.0

1.1

u/ml

5.1

3.5

0.47

677

(3006922) Hepatitis E virus Ab [Presence] in Serum

167

1297

1.10

0.61

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

641

1.15

0.61

1.7

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.61

0.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

120

0.64

0.61

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

186

1.29

0.60

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.59

0.60

1.1

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

172

1.30

0.58

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

198

0.74

0.57

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.40

0.57

1.1

1.0

u/ml

0.2

0.7

—

(40768446) Kidney Pathology biopsy report

794

0.87

0.56

1.4

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.66

0.56

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

346

2784

1.07

0.56

4.4

5.1

umol/l

334.4

369.7

4.56

297

2397

(3029634) Reagin Ab [Titer] in Serum by VDRL

245

2263

0.93

0.55

1.9

2.3

titre

0.8

7.9

—

(40765096) Chromosome analysis panel by Banding

599

0.86

0.54

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

114

1.35

0.54

1.0

u/ml

0.1

0.78

(40768441) Liver Pathology biopsy report

189

1490

1.09

0.53

1.3

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

422

0.83

0.53

5.0

6.1

—

(40768793) Breast Pathology biopsy report

508

4576

0.95

0.53

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.43

0.52

1.0

—

(3033799) Differential panel - Peritoneal fluid

688

0.87

0.52

1.7

1.9

—

(3024316) Viscosity of Plasma

1.43

0.52

1.6

1.7

mpas

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

813

0.89

0.50

1.6

1.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

317

1.19

0.50

1.6

1.4

12.5

12.4

0.01

156

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

154

0.72

0.50

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

602

0.87

0.49

1.8

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

208

1.24

0.49

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

695

1.12

0.49

1.7

1.4

iu/ml

4781606.2

1768288.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.63

0.48

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

366

1.17

0.48

2.2

6.1

u/l

76.2

49.9

0.48

152

(40762887) Creatinine [Moles/volume] in Blood

1.46

0.47

1.4

1.3

—

(3003577) Lead [Moles/volume] in Blood

140

1.29

0.47

1.2

1.4

umol/l

0.1

0.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

135

1057

1.10

0.47

1.1

—

(3014891) Appearance of Pleural fluid

304

0.82

0.46

1.4

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

210

1.23

0.46

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

369

1.16

0.44

1.1

1.2

mmol/l

1.7

0.02

221

(3004446) Plasmodium sp identified in Blood by Light microscopy

157

1.26

0.44

1.8

2.6

—

(3025315) Body weight

173

1.24

0.43

5.0

4.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.64

0.42

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.41

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

380

1.15

0.41

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

253

1.19

0.40

2.7

3.1

umol/l

39.7

41.2

0.15

220

(3006576) Bicarbonate [Moles/volume] in Blood

665

1.11

0.40

4.3

6.4

mmol/l

25.5

25.1

0.33

595

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

214

1.20

0.40

1.2

1.1

u/l

29.0

19.5

0.87

143

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.32

0.40

1.0

1.1

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

439

1.13

0.39

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

160

1.23

0.38

3.6

2.4

mmol/l

0.7

1.0

0.42

106

(3029396) Erythrocyte agglutination [Presence] in Blood

145

1.24

0.37

2.7

2.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.30

0.37

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

433

1.13

0.37

1.5

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

211

0.81

0.36

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

321

0.85

0.35

5.4

7.2

—

(3044009) aPTT.lupus sensitive (LA screen)

139

1.23

0.34

1.1

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.35

0.34

2.0

2.2

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.32

0.33

1.2

1.0

pmol/l

268.7

232.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

779

0.91

0.33

1.7

1.9

e6/l

11530.6

2454.6

0.39

521

(3045142) Bone marrow Pathology biopsy report

280

2291

1.05

0.32

1.3

—

(40768795) Lymph node Pathology biopsy report

245

2208

0.95

0.32

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

625

0.91

0.32

1.6

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

196

1.18

0.32

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

414

1.12

0.31

8.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

397

0.89

0.30

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

270

1.14

0.29

1.1

—

(3035880) pH of Pleural fluid

139

1119

1.07

0.29

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

556

1.10

0.29

3.5

3.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

198

1.17

0.29

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.73

0.29

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

789

0.92

0.28

1.0

u/ml

0.1

1.1

0.64

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

451

1.10

0.28

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

104

0.74

0.27

2.1

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

121

974

1.07

0.26

3.9

6.2

u/ml

2238.2

4227.1

0.22

209

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

626

0.92

0.26

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

184

1.17

0.26

1.0

1.1

u/ml

0.0

0.6

0.75

133

(3049242) von Willebrand panel - Platelet poor plasma

0.69

0.26

1.0

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

147

0.82

0.26

1.8

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

544

0.91

0.25

1.1

1.3

g/l

12.8

13.4

0.19

431

(3032352) Blasts [#/volume] in Cerebral spinal fluid

193

1.16

0.25

1.1

1.8

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.17

0.24

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.17

0.24

1.0

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.73

0.24

1.0

1.2

—

14.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

259

1.13

0.24

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

154

1.17

0.23

1.8

2.2

—

(3017509) Phencyclidine [Presence] in Urine

138

1.18

0.23

1.3

1.4

—

(3019174) dRVVT (LA screen)

138

1.18

0.23

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

399

1.10

0.23

1.7

1.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.26

0.23

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.76

0.22

5.3

5.9

umol/l

331.6

417.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

226

0.87

0.22

1.1

2.2

mmol/l

7.2

7.4

0.10

101

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.21

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

344

1.10

0.21

2.9

2.8

u/l

376.4

1833.2

2.07

307

(3027974) Hepatitis B virus e Ag [Presence] in Serum

106

0.81

0.20

2.0

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

116

1.18

0.20

4.8

4.9

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.25

0.20

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

157

1.15

0.19

5.3

4.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

192

1584

1.04

0.19

1.0

u/ml

0.3

0.6

0.75

314

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

632

0.94

0.19

2.2

1.7

u/ml

106687.3

11085.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

182

1.13

0.19

2.3

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

252

2093

1.03

0.18

3.7

3.8

—

(40758292) HTLV I+II Ab panel - Serum

302

0.91

0.17

1.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.13

0.17

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.21

0.17

1.2

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.11

0.17

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.75

0.17

1.2

1.0

—

(3034426) Prothrombin time (PT)

599

1.06

0.16

1.3

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.16

0.16

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

135

1.14

0.16

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

264

0.91

0.15

1.3

1.2

nmol/l

32.1

28.9

0.12

226

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

112

921

1.04

0.15

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

112

921

1.04

0.15

1.3

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

368

1.07

0.14

1.5

1.4

mmol/l

8.7

8.5

0.16

215

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

650

0.95

0.14

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

110

0.86

0.13

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

370

1.07

0.13

3.2

3.1

ng/l

61.8

121.1

1.08

127

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

105

1.14

0.13

1.0

u/ml

0.0

0.6

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

172

0.90

0.13

1.3

1.4

ml/s/173m2

1.0

1.1

—

107

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

481

1.05

0.11

8.2

8.3

—

(40768806) Pleura Pathology biopsy report

259

2268

0.98

0.11

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

1132

1.03

0.11

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

156

1.10

0.11

1.0

—

(44806420)

625

0.96

0.10

2.5

2.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

240

0.93

0.10

1.2

1.3

u/l

1461.4

217.8

0.41

170

(3023199) Leukocytes [#/volume] in Pleural fluid

289

2522

0.98

0.10

1.4

1.5

e6/l

2646.5

2722.8

0.05

197

1818

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

358

1.05

0.09

1.5

1.8

ug/l

2.7

3.0

0.09

224

(3014599) Egg white IgE Ab [Units/volume] in Serum

108

900

1.03

0.09

1.0

u/ml

0.7

1.6

0.71

194

(3003740) Influenza virus B Ag [Presence] in Specimen

296

2498

1.02

0.09

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.07

0.08

1.0

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

242

1.06

0.08

4.5

7.8

umol/l

0.4

0.00

220

(3052592) Norovirus Ag [Presence] in Stool

361

1.05

0.07

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

488

1.04

0.07

1.5

1.3

g/l

129.0

25.5

0.50

382

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

689

0.97

0.07

1.6

1.8

e6/l

8599.1

11421.4

0.23

365

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

181

1525

1.02

0.07

1.3

u/l

13.0

14.1

0.46

170

1413

(3013762) Body weight Measured

0.82

0.07

1.3

1.1

—

(3048879) Bone marrow aspiration report

582

1.03

0.07

1.9

1.8

—

(40760409) HLA-A [Type] by High resolution

1.04

0.07

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.04

0.07

1.0

—

(40760410) HLA-B [Type] by High resolution

1.04

0.07

1.0

—

(40763590) HLA-DQ beta [Type]

1.04

0.07

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.87

0.06

1.2

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

787

1.02

0.06

2.4

2.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

113

0.91

0.06

1.0

u/ml

0.0

0.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

779

1.02

0.06

2.4

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

780

1.02

0.05

2.4

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

294

2495

1.01

0.05

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

112

0.92

0.05

1.0

u/ml

0.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

442

0.97

0.05

1.2

—

(1761868) Lipid panel - Serum or Plasma

8504

73007

1.00

0.04

3.3

2.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

323

1.04

0.04

1.2

1.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.10

0.04

1.2

1.5

2.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

163

0.95

0.04

2.5

2.2

—

(3012441) Differential panel - Pleural fluid

260

2212

1.01

0.03

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

144

0.95

0.02

2.2

3.1

—

(3045788) Cell count panel - Pleural fluid

229

1952

1.01

0.02

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

273

0.97

0.02

1.2

1.3

27.0

25.4

0.08

215

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

1.05

0.01

1.1

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

143

0.96

0.01

4.4

6.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

311

1.02

0.01

1.2

ng/l

97.8

120.0

0.18

211

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

223

1904

1.00

0.01

1.3

u/l

553.8

485.4

0.27

208

1811

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

184

1585

1.00

0.01

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

267

2297

1.00

0.01

1.4

1.5

e6/l

73047.2

52915.4

0.46

155

1365

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

112

1.00

0.00

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.99

0.00

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

275

1.00

0.00

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

384

1.00

0.00

1.1

1.0

u/ml

22.7

10.9

—

(3012898) Urea [Moles/volume] in Urine

200

0.99

0.00

1.1

1.4

mmol/l

185.8

162.3

0.53

173

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

206

1765

1.00

0.00

1.7

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

219

0.98

0.00

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

295

0.99

0.00

1.2

mmol/l

0.6

1.3

0.77

183

(3023383) Lactate [Moles/volume] in Pleural fluid

615

1.00

0.00

1.2

1.3

mmol/l

3.4

0.03

573

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

587

0.99

0.00

1.3

ug/l

155.5

309.8

0.57

318

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

110

1.01

0.00

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

276

0.99

0.00

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

276

0.99

0.00

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

331

2835

1.00

0.00

1.5

1.4

g/l

33.5

33.0

0.26

304

2534

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.95

0.00

1.0

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

1.6

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

0.0

1.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.95

0.00

1.0

1.1

—

(3036566) Thyroxine binding globulin [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

358.7

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3013862) HLA-DP [Type]

1.00

0.00

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.89

0.00

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.89

0.00

1.3

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.86

0.00

1.6

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.00

0.00

1.2

1.1

nmol/l

246.7

268.3

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.97

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLOSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONDYLOSIS	1.053 [0.97, 1.14]	0.215
Birth year	0.997 [0.99, 1.0]	0.433

During the follow-up period (1.1.1998 — 31.12.2019), 11491 out of 73198 females with M13_SPONDYLOSIS died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONDYLOSIS	1.072 [0.99, 1.17]	0.101
Birth year	0.991 [0.98, 1.0]	0.041

During the follow-up period (1.1.1998 — 31.12.2019), 11365 out of 61023 males with M13_SPONDYLOSIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLOSIS.

N-year risk	Females	Males
1	0.087%	0.197%
5	0.614%	1.34%
10	1.545%	3.54%
15	2.974%	6.731%
20	5.326%	11.351%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLOSIS – Spondylosis

GWS hits: 20

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Spondylosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints